<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/ProjectMundo/style/jats-html.xsl"?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-45446-1
   </article-id>
   <article-id pub-id-type="manuscript">
    45446
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-45446-1
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/2056
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /631/208/205
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /45
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /45/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     Watoto walirozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu mara nyingi huchukua aina ya kijeni ya mitochondrial inayohusiana na uzito mdogo wa kuzaliwa
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" id="Au1">
     <name name-style="western">
      <surname>
       Mertens
      </surname>
      <given-names>
       Joke
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <name name-style="western">
      <surname>
       Belva
      </surname>
      <given-names>
       Florence
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <name name-style="western">
      <surname>
       van Montfoort
      </surname>
      <given-names>
       Aafke P. A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       Regin
      </surname>
      <given-names>
       Marius
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Zambelli
      </surname>
      <given-names>
       Filippo
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Seneca
      </surname>
      <given-names>
       Sara
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Couvreu de Deckersberg
      </surname>
      <given-names>
       Edouard
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Bonduelle
      </surname>
      <given-names>
       Maryse
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Tournaye
      </surname>
      <given-names>
       Herman
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <name name-style="western">
      <surname>
       Stouffs
      </surname>
      <given-names>
       Katrien
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <name name-style="western">
      <surname>
       Barbé
      </surname>
      <given-names>
       Kurt
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-3859-8522
     </contrib-id>
     <name name-style="western">
      <surname>
       Smeets
      </surname>
      <given-names>
       Hubert J. M.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Van de Velde
      </surname>
      <given-names>
       Hilde
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <name name-style="western">
      <surname>
       Sermon
      </surname>
      <given-names>
       Karen
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <name name-style="western">
      <surname>
       Blockeel
      </surname>
      <given-names>
       Christophe
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au16">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-0187-5138
     </contrib-id>
     <name name-style="western">
      <surname>
       Spits
      </surname>
      <given-names>
       Claudia
      </given-names>
     </name>
     <address>
      <email>
       claudia.spits@vub.be
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs41467024454461_cor16">
      s
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Reproduction and Genetics, Faculty of Medicine and Pharmacy
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="GRID">
       grid.411326.3
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0626 3362
      </institution-id>
      <institution content-type="org-name">
       Center for Medical Genetics, UZ Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       Department of Obstetrics &amp; Gynaecology, GROW School for Oncology and Developmental Biology
      </institution>
      <institution content-type="org-name">
       Maastricht University Medical Center
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution content-type="org-division">
       Basic Research Laboratory
      </institution>
      <institution content-type="org-name">
       Eugin Group
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Barcelona
     </addr-line>
     <country country="ES">
      Spain
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="GRID">
       grid.411326.3
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0626 3362
      </institution-id>
      <institution content-type="org-name">
       Brussels IVF, Center for Reproductive Medicine, UZ Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Biology of the Testis, Faculty of Medicine
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Interfaculty Center Data Processing &amp; Statistics
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       Department of Toxicogenomics
      </institution>
      <institution content-type="org-name">
       Maastricht University
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/02jz4aj89
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.5012.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0481 6099
      </institution-id>
      <institution content-type="org-division">
       MHeNs School Institute for Mental Health and Neuroscience, GROW Institute for Oncology and Developmental Biology
      </institution>
      <institution content-type="org-name">
       Maastricht University
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Maastricht
     </addr-line>
     <country country="NL">
      The Netherlands
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/006e5kg04
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8767.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2290 8069
      </institution-id>
      <institution content-type="org-division">
       Research Group Reproduction and Immunology, Faculty of Medicine and Pharmacy
      </institution>
      <institution content-type="org-name">
       Vrije Universiteit Brussel
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Brussels
     </addr-line>
     <country country="BE">
      Belgium
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00mv6sv71
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.4808.4
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 0657 4636
      </institution-id>
      <institution content-type="org-division">
       Department of Obstetrics and Gynaecology, School of Medicine
      </institution>
      <institution content-type="org-name">
       University of Zagreb
      </institution>
     </institution-wrap>
     <addr-line content-type="street">
      Šalata 3
     </addr-line>
     <addr-line content-type="postcode">
      10000
     </addr-line>
     <addr-line content-type="city">
      Zagreb
     </addr-line>
     <country country="HR">
      Croatia
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs41467024454461_cor16">
     <label>
      s
     </label>
     <email>
      claudia.spits@vub.be
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     9
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1232">
    1
   </issue>
   <elocation-id>
    1232
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      24
     </day>
     <month>
      1
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      10
     </day>
     <month>
      12
     </month>
     <year>
      2022
     </year>
    </date>
    <date date-type="accepted">
     <day>
      23
     </day>
     <month>
      1
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      9
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <abstract id="Abs1" xml:lang="en">
    <title>
     Maelezo ya Mfupi
    </title>
    <p id="Par1">
     Watoto waliopatikana kupitia teknolojia za uzazi uliofungamana na usaidizi wa kimatibabu (ART) wana hatari kubwa ya kuwa na uzito mdogo wa kuzaliwa, lakini sababu kuu bado haijulikani. Tafiti yetu zinachunguza aina za DNA ya mitochondrial (mtDNA) kama wachangiaji wa tofauti za uzito wa kuzaliwa kwa athari ya utendaji wa mitochondrial wakati wa ukuzaji wa kabla ya kuzaliwa. Tuliendesha kwa kina mtDNA ya watu 451 wa ART na watu waliopatikana kwa njia asilia (SC), jozi 157 za mama na mtoto na ova 113 za mtu binafsi kutoka kwa mizunguko ya kawaida ya mwezi au baada ya kuchochea ovari (OS) na kupata kwamba watu wa ART walibeba aina tofauti ya mtDNA genotype kuliko watu wa SC, na kuwa na vigeu vingi zaidi vya de novo non-synonymous. Vigeu hivi, pamoja na vigeu vya rRNA, vinahusiana na asilimia za chini za uzito wa kuzaliwa, bila kujali njia ya kupata uzazi. Kuwepo kwao kwa wingi zaidi kwa watu wa ART kunatokana na de novo mutagenesis inayohusiana na kuzeeka kwa umri wa mama na ukubwa wa ova uliochochewa na OS. Tafiti za siku zijazo zitabainisha matokeo ya muda mrefu ya afya ya mabadiliko haya na jinsi matokeo haya yataathiri mazoezi ya kimatibabu na ushauri wa mgonjwa katika siku zijazo.
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Assisted reproduction increases low birthweight risk in children. This study finds a mitochondrial DNA genotype that is more common in ART children, associates to birthweight and that is linked to maternal ageing and to ovarian stimulation.
    </p>
   </abstract>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1114">
      Paediatrics and Reproductive Medicine
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100003130
       </institution-id>
      </institution-wrap>
     </funding-source>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      1232
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      24
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_45446.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    Uanzishaji
   </title>
   <p id="Par3">
    Kuzaliwa kwa Louise Brown mwaka 1978 kilionyesha kuanza kwa mapinduzi katika dawa za uzazi ambayo imewezesha wazazi waliokata tamaa kupata watoto. Tangu wakati huo, teknolojia za uzazi zimeendelea kwa kasi kubwa na matumizi yake yameongezeka kwa kasi, na zaidi ya watoto milioni 8 wamezaliwa duniani kote. Katika miaka ya karibu zilizopita, hatua zote za mchakato huu zimepitia marekebisho ya mara kwa mara. Hata hivyo, wasiwasi kuhusu usalama wa taratibu hizi kuhusiana na afya ya watoto waliozaliwa baada ya ART daima imekuwepo, na utafiti wa kimfumo wa vikundi vikubwa vya watoto kwa miaka mingi imeonyesha kwamba watoto hawa kwa kweli wana matokeo mabaya ya afya ikilinganishwa na wale waliozaliwa baada ya uzazi wa asili (SC). Kuna ushahidi mkubwa sasa kwamba watoto wa ART wana hatari kubwa ya kuzaliwa na ulemavu wa kuzaliwa na uzito mdogo kwa umri wa ujauzito, na watoto wa ART wana hatari kubwa zaidi ya matokeo mabaya ya kabla ya kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     ,
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     ,
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     ,
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
    </sup>
    . Kinyume chake, watoto waliozaliwa baada ya ubadilishaji wa embrio lililofungwa hana hatari kubwa ya kuzaliwa na uzito mkubwa kwa umri wa ujauzito, ambao unahusiana na matatizo ya kuzaliwa, magonjwa ya utoto na matatizo ya moyo na kimetaboliki
    <sup>
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     ,
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    . Mafunzo ya muda mrefu ya utafiti yanaonyesha kuongezeka kwa ushahidi kwamba watoto hawa wako hatarini kwa ajili ya viwango visivyo vya kawaida vya homoni na kimetaboliki baadaye maishani
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
     ,
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     ,
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     ,
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
     ,
     <xref ref-type="bibr" rid="CR12">
      12
     </xref>
     ,
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     ,
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
    </sup>
    .
   </p>
   <p id="Par4">
    Katika miaka ya karibu zilizopita, utafiti mkubwa umetolewa kwa kutambua sababu na msingi wa molekuli wa athari hizi mbaya kwa watoto wa ART, kulingana na ujuzi kwamba hali zisizofaa za maendeleo ya mapema zina athari kubwa kwa afya ya mtu baadaye
    <sup>
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
    </sup>
    . Mambo matatu yamechunguzwa hasa kuhusiana na afya ya watoto wa ART, yaani ukosefu wa uzazi wa kike, kichocheo cha ovari (OS) na mifumo ya utunzaji wa embrio. Hata hivyo, matokeo yanayokinzana mara nyingi ya utafiti tofauti hufanya iwe vigumu kubainisha jukumu la kila kipengele katika tabia ya watoto. Kwanza, matokeo mabaya ya afya yaliyoonekana kwa watoto wa ART yamehusishwa na ukosefu wa uzazi wa mamake zao
    <sup>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
     ,
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
     ,
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
    </sup>
    . Kwa mujibu wa hili, watoto wa SC waliozaliwa na mamake wasio na uzazi pia wana hatari kubwa ya matokeo mabaya ya kabla ya kuzaliwa, ikipendekeza jukumu kubwa kwa mazingira ya kimatibabu (kijeni) ya mama. Pili, utaratibu wa OS, unaotumika katika ART ili kuongeza kikundi cha oocytes zinazopatikana katika mzunguko mmoja wa mwezi wa hedhi umeonyeshwa kuathiri uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     ,
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     ,
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
    </sup>
    . Imependekezwa kuwa mazingira ya kimatibabu ya mama chini ya ushawishi wa OS hufanya kazi kama mchangiaji huru kwa hatari ya uzito mdogo wa kuzaliwa kwa watoto waliozaliwa baada ya ubadilishaji wa embrio wa tarehe moja, kwa kulinganisha na ubadilishaji wa embrio lililofungwa
    <sup>
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    . Hata hivyo, utafiti wa pamoja wa watoto waliozaliwa baada ya OS na watoto wa SC kutoka kwa wazazi wasio na uzazi hawakupata tofauti za kimaana
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     ,
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    . Tatu, usakinishaji wa embrio wa ndani, ikijumuisha kufungwa na kuchaji, na hasa matumizi ya vyombo tofauti vya utunzaji vimeonyeshwa kuwa na athari kubwa kwa uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR24">
      24
     </xref>
     ,
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     ,
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
    </sup>
    . Kwa sababu vituo vya ART duniani kote hutumia vyombo tofauti, na hivi viwanda vimeendelea kwa wakati, kubainisha athari halisi na sababu zinazohusika katika vyombo kwenye afya ya mtoto wa ART kunabaki kuwa changamoto
    <sup>
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
     ,
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    .
   </p>
   <p id="Par5">
    Kutoka kwa mtazamo wa molekuli, utafiti mkubwa umelenga kutafuta mabadiliko ya epigenetic yanayosababishwa na ART, katika watu binafsi na katika sampuli za plasenta. Ingawa idadi kubwa ya utafiti wa wanyama imeonyesha uhusiano kati ya mabadiliko ya epigenetic na vipengele tofauti vya ART, utafiti katika binadamu haujaleta matokeo ya kuhitimisha
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
    </sup>
    . Wakati baadhi ya utafiti umegundua tofauti katika mazingira ya epigenetic ya watoto wa ART na SC, hizi mara nyingi zilikuwa ndani ya safu ya kawaida ya mabadiliko. Watafiti wengi wengine hawajapata mabadiliko ya mara kwa mara ya methylation katika jeni ya watoto wa ART, na kusababisha matokeo ambayo yote ni vigumu kufanana na matokeo ya afya ya watoto wa ART. Hatimaye, utafiti wa hivi karibuni ulionyesha kuwa uzazi wa ndani hauongezi kiwango cha hitilafu za kromosomu katika mstari wa fetal na plasenta wa binadamu, na haikupata uhusiano kati ya kuwepo kwa hitilafu hizi na uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
     ,
     <xref ref-type="bibr" rid="CR31">
      31
     </xref>
     <xref ref-type="bibr" rid="CR32">
      32
     </xref>
     ,
     <xref ref-type="bibr" rid="CR33">
      33
     </xref>
     ,
     <xref ref-type="bibr" rid="CR34">
      34
     </xref>
     ,
     <xref ref-type="bibr" rid="CR35">
      35
     </xref>
     ,
     <xref ref-type="bibr" rid="CR36">
      36
     </xref>
     <xref ref-type="bibr" rid="CR37">
      37
     </xref>
    </sup>
    .
   </p>
   <p id="Par6">
    Katika utafiti huu, tulidhania kuwa tofauti katika uzito wa kuzaliwa kati ya watoto wa ART na SC husababishwa na aina za DNA ya mitochondrial (mtDNA). Katika idadi ya watu kwa ujumla, uzito mdogo wa kuzaliwa unahusiana na matatizo ya kimetaboliki, ambayo katika uzazi umegundishwa kuwa na uhusiano na utendakazi usiofaa wa mitochondrial
    <sup>
     <xref ref-type="bibr" rid="CR38">
      38
     </xref>
     <xref ref-type="bibr" rid="CR39">
      39
     </xref>
    </sup>
    . Zaidi ya hayo, hitilafu zilizopitishwa za mtDNA zinaweza kufanya mtu kuwa na hatari ya kuwa na uzani wa juu na upinzani wa insulini, uzito mdogo wa kuzaliwa ni wa kawaida kwa watu waliozaliwa na ugonjwa wa mtDNA na mabadiliko yasiyo ya ugonjwa ya mtDNA yamepatikana kuwa na uhusiano na muundo wa mwili na uzito
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
     <xref ref-type="bibr" rid="CR41">
      41
     </xref>
     ,
     <xref ref-type="bibr" rid="CR42">
      42
     </xref>
     <xref ref-type="bibr" rid="CR43">
      43
     </xref>
     ,
     <xref ref-type="bibr" rid="CR44">
      44
     </xref>
     ,
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR46">
      46
     </xref>
     ,
     <xref ref-type="bibr" rid="CR47">
      47
     </xref>
     ,
     <xref ref-type="bibr" rid="CR48">
      48
     </xref>
     ,
     <xref ref-type="bibr" rid="CR49">
      49
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
    </sup>
    . Kama ilivyotajwa awali, ukosefu wa uzazi wa kike na OS kwa nguvu zinahusiana na hatari ya uzito mdogo wa kuzaliwa kwa watoto wa ART, na zote mbili zinaweza kuwa na uhusiano na utendakazi wa mitochondrial kwa sababu usakinishaji wa oksijeni una jukumu muhimu wakati wa uundaji wa gameti, maendeleo ya embryonic na pia katika ukosefu wa uzazi wa kike
    <sup>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     ,
     <xref ref-type="bibr" rid="CR51">
      51
     </xref>
     <xref ref-type="bibr" rid="CR52">
      52
     </xref>
     ,
     <xref ref-type="bibr" rid="CR53">
      53
     </xref>
     ,
     <xref ref-type="bibr" rid="CR54">
      54
     </xref>
     ,
     <xref ref-type="bibr" rid="CR55">
      55
     </xref>
     ,
     <xref ref-type="bibr" rid="CR56">
      56
     </xref>
     ,
     <xref ref-type="bibr" rid="CR57">
      57
     </xref>
     ,
     <xref ref-type="bibr" rid="CR58">
      58
     </xref>
    </sup>
    . Tulidhania kuwa wanawake wasio na uzazi mara nyingi huchukua aina za mtDNA ambazo zinathiri vibaya utendakazi wa mitochondrial na kuchangia ukosefu wao wa uzazi. Zaidi ya hayo, kazi katika miundo ya wanyama inapendekeza kuwa OS huongeza mara kwa mara ya uharibifu wa mtDNA katika oocytes na kuthiri utendakazi wa mitochondrial
    <sup>
     <xref ref-type="bibr" rid="CR59">
      59
     </xref>
     ,
     <xref ref-type="bibr" rid="CR60">
      60
     </xref>
     <xref ref-type="bibr" rid="CR61">
      61
     </xref>
    </sup>
    . Kwa hiyo, tulidhania kuwa uhamishaji wa mtDNA genotypes ya mama, ambayo inaweza kuhusiana na ukosefu wa uzazi, na utengenezaji wa de novo wakati wa OS unaweza kusababisha matokeo mabaya ya kabla ya kuzaliwa kwa watoto wanaobeba aina hizi za mtDNA.
   </p>
   <p id="Par7">
    Ili kujaribu kama aina za mtDNA za watoto wa ART na SC zinatofautiana, ikiwa tofauti hizi zinahusiana na uzito wa kuzaliwa na asilimia, na kubainisha asili ya tofauti hizi zinazowezekana, tulichunguza jeni ya mitochondrial ya watoto 270 wa ART na 181 wa SC, jozi 157 za mama na mtoto wa ART na SC, na oocytes 113 zilizotolewa katika mizunguko ya asili ya mwezi wa hedhi na baada ya OS kutoka kwa wadonaji sawa kwa kutumia utaratibu wa kuendesha kwa wingi.
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    Matokeo
   </title>
   <sec id="Sec3">
    <title>
     Watoto walirozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu wanaonyesha aina tofauti ya kijeni ya DNA ya mitochondrial ikilinganishwa na wenzao walirozaliwa kwa njia asilia
    </title>
    <p id="Par8">
     Kwanza, tuliandika jeni ya mitochondrial kamili ya watoto 270 wa ART na 181 wa SC (maelezo kuhusu washiriki na chanzo cha DNA yanaweza kupatikana kwenye Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     ). Wakati wa uchakataji wa data, tulipata 1037 bp ambayo ilijumuisha maeneo ambayo yalikuwa na hatari ya makosa ya PCR na kuandika upya (Fig.
     <xref ref-type="fig" rid="Fig1">
      1a
     </xref>
     ).
     <fig id="Fig1" position="float">
      <label>
       Fig. 1
      </label>
      <caption xml:lang="sw">
       <title>
        Watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu mara nyingi huchukua aina ya kijeni ya mitochondrial inayohusiana na uzito mdogo wa kuzaliwa.
       </title>
       <p>
        <bold>
         a
        </bold>
        Muundo wa jumla wa mtDNA unaonyesha kwa rangi ya njano maeneo ambayo yaliondolewa kutoka kwa uchambuzi. Imetolewa na ruhusa ya ref.
        <sup>
         <xref ref-type="bibr" rid="CR112">
          112
         </xref>
        </sup>
        , Copyright 2009 International Union of Biochemistry and Molecular Biology, Inc.
        <bold>
         b
        </bold>
        ,
        <bold>
         c
        </bold>
        Jaribio la Fisher’s exact linashuhudia hakuna tofauti muhimu katika upatikanaji wa haplogroups tofauti (
        <bold>
         b
        </bold>
        ) na subhaplogroups (
        <bold>
         c
        </bold>
        ) kati ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa njia ya asili.
        <bold>
         d
        </bold>
        Jaribio la Fisher’s exact linashuhudia hakuna tofauti muhimu katika upatikanaji wa watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa njia ya asili wenye variants homoplasmic zilizopo katika makundi tofauti. Asilimia hazijumlishi hadi 100% kwa sababu mtu mmoja anaweza kuwa na zaidi ya moja variant.
        <bold>
         e
        </bold>
        Muhtasari wa variants zote za heteroplasmic zilizopatikana. Vigezo vinne vya tRNA havikuwakilishwa katika seti yetu ya data. Kila mpira unawakilisha variant moja na ukubwa wa mpira ni sawia na uzito wa variant.
        <bold>
         f
        </bold>
        ,
        <bold>
         g
        </bold>
        Jumla ya uzito wa variants zilizopatikana kwa kila sampuli, zilizopangwa kulingana na asili ya tishu (
        <bold>
         f
        </bold>
        ) na umri wa sampuli (
        <bold>
         g
        </bold>
        ). Jaribio la Kruskal–Wallis linashuhudia hakuna tofauti muhimu. Damu
        <italic>
         n
        </italic>
        = 168, Placenta
        <italic>
         n
        </italic>
        = 117, Saliva na Swab ya Buccal
        <italic>
         n
        </italic>
        = 166, wakati wa kuzaliwa
        <italic>
         n
        </italic>
        = 163, miaka 9
        <italic>
         n
        </italic>
        = 106, miaka 18
        <italic>
         n
        </italic>
        = 182.
        <bold>
         h
        </bold>
        Idadi ya variants zilizopatikana kwa kila mtu. Jaribio la chi-square linashuhudia hakuna tofauti muhimu (variants zisizo za maana,
        <italic>
         p
        </italic>
        = 0.067).
        <bold>
         i
        </bold>
        Kiwango cha mabadiliko kwa kila eneo au jeni ya kuamsha protein, kwa kila mtu katika uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa njia ya asili.
        <bold>
         j
        </bold>
        Jumla ya uzito wa variants za heteroplasmic zilizopatikana kwa kila mtu na kwa kila eneo. Jaribio la Mann–Whitney U linashuhudia hakuna tofauti muhimu.
        <italic>
         n
        </italic>
        = 270 uzazi uliofungamana na usaidizi wa kimatibabu,
        <italic>
         n
        </italic>
        = 181 waliokuzaliwa kwa njia ya asili.
        <bold>
         k
        </bold>
        Matrix ya vipengele iliyotokana na uchambuzi wa vipengele.
        <bold>
         l
        </bold>
        Hypercube inayowakilisha uhusiano kati ya makundi tofauti ya variants za heteroplasmic. Rangi zinaonyesha makundi yanayohusiana katika kipengele sawa.
        <bold>
         m
        </bold>
        Watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu mara nyingi huchukua alama za juu zaidi kwa kipengele cha 2 (*Jaribio la Mann–Whitney U,
        <italic>
         p
        </italic>
        = 0.021).
        <italic>
         n
        </italic>
        = 270 uzazi uliofungamana na usaidizi wa kimatibabu,
        <italic>
         n
        </italic>
        = 181 waliokuzaliwa kwa njia ya asili. Mistari ya wima katika sehemu (
        <bold>
         f
        </bold>
        ), (
        <bold>
         g
        </bold>
        ), (
        <bold>
         j
        </bold>
        ) na (
        <bold>
         m
        </bold>
        ) inawakilisha wastani wa thamani katika grafu ya nukta, kila nukta inawakilisha sampuli. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
     <table-wrap id="Tab1">
      <label>
       Table 1
      </label>
      <caption xml:lang="en">
       <p>
        Sifa za watu waliochukuliwa katika utafiti huu wa ART na SC
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th rowspan="2"/>
         <th>
          <p>
           ART
          </p>
         </th>
         <th>
          <p>
           SC
          </p>
         </th>
         <th rowspan="2">
          <p>
           <italic>
            P
           </italic>
           -value
          </p>
         </th>
        </tr>
        <tr>
         <th>
          <p>
           (
           <italic>
            N
           </italic>
           = 270)
          </p>
         </th>
         <th>
          <p>
           (
           <italic>
            N
           </italic>
           = 181)
          </p>
         </th>
        </tr>
        <tr>
         <th/>
         <th colspan="2">
          <p>
           % (
           <italic>
            N
           </italic>
           )
          </p>
         </th>
         <th/>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            NYENZO ZA CHUO
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Damu
           <sup>
            1
           </sup>
          </p>
         </td>
         <td>
          <p>
           38.1% (103)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Watoto wachanga
          </p>
         </td>
         <td>
          <p>
           17.0% (46)
          </p>
         </td>
         <td>
          <p>
           0.0% (0)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vijana waliokomaa
          </p>
         </td>
         <td>
          <p>
           21.1% (57)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Plasenta
           <sup>
            2
           </sup>
          </p>
         </td>
         <td>
          <p>
           24.4% (66)
          </p>
         </td>
         <td>
          <p>
           28.2% (51)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Cellu za mdomo
           <sup>
            3
           </sup>
           &amp; Kunywa
           <sup>
            2
           </sup>
          </p>
         </td>
         <td>
          <p>
           37.4% (101)
          </p>
         </td>
         <td>
          <p>
           35.9% (65)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Watoto
          </p>
         </td>
         <td>
          <p>
           37.4% (101)
          </p>
         </td>
         <td>
          <p>
           2.8% (5)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vijana waliokomaa
          </p>
         </td>
         <td>
          <p>
           0.0% (0)
          </p>
         </td>
         <td>
          <p>
           33.1% (60)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Mama na mtoto
          </p>
         </td>
         <td>
          <p>
           67
          </p>
         </td>
         <td>
          <p>
           90
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            VIPIMO VYA KILINIKI
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Wastani wa umri wa mama
           <sup>
            4
           </sup>
           ± SD*
          </p>
         </td>
         <td>
          <p>
           32.5 ± 3.7 (211)
          </p>
         </td>
         <td>
          <p>
           30.1 ± 4.4 (173)
          </p>
         </td>
         <td>
          <p>
           &lt;0.0001
           <sup>
            a
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Maternal BMI &gt; 25*
          </p>
         </td>
         <td>
          <p>
           40.2% (86/214)
          </p>
         </td>
         <td>
          <p>
           25.6% (42/164)
          </p>
         </td>
         <td>
          <p>
           0.0031
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Uzito wa kuzaliwa*
          </p>
         </td>
         <td>
          <p>
           (224)
          </p>
         </td>
         <td>
          <p>
           (164)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Wastani (gramu) ± SD
          </p>
         </td>
         <td>
          <p>
           3377.9 ± 536.0
          </p>
         </td>
         <td>
          <p>
           3394.3 ± 500.7
          </p>
         </td>
         <td>
          <p>
           0.7596
           <sup>
            a
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           &lt;10th percentile
          </p>
         </td>
         <td>
          <p>
           7.0% (19)
          </p>
         </td>
         <td>
          <p>
           5.0% (9)
          </p>
         </td>
         <td>
          <p>
           0.2407
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           &lt;25th percentile
          </p>
         </td>
         <td>
          <p>
           15.2% (41)
          </p>
         </td>
         <td>
          <p>
           14.4% (26)
          </p>
         </td>
         <td>
          <p>
           0.4992
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuzaliwa mapema (&lt;37 weeks)*
          </p>
         </td>
         <td>
          <p>
           5.8% (13/224)
          </p>
         </td>
         <td>
          <p>
           6.1% (10/164)
          </p>
         </td>
         <td>
          <p>
           1.0000
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Jinsia*
          </p>
         </td>
         <td>
          <p>
           (224)
          </p>
         </td>
         <td>
          <p>
           (181)
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           (Mwanaume – Mwanamke)
          </p>
         </td>
         <td>
          <p>
           41.5% (112) –41.5% (112)
          </p>
         </td>
         <td>
          <p>
           44.8% (81) –55.2% (100)
          </p>
         </td>
         <td>
          <p>
           0.3176
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Medium ya utamaduni
          </p>
         </td>
         <td>
          <p>
           224
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vitrolife® G3
          </p>
         </td>
         <td>
          <p>
           19.3% (52)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Vitrolife® G5
          </p>
         </td>
         <td>
          <p>
           24.4% (66)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Cook®
          </p>
         </td>
         <td>
          <p>
           18.1% (49)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           UZB
          </p>
         </td>
         <td>
          <p>
           21.1% (57)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Unknown
          </p>
         </td>
         <td>
          <p>
           17.0% (46)
          </p>
         </td>
         <td>
          <p>
           NA
          </p>
         </td>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           Magonjwa ya ujauzito*
          </p>
         </td>
         <td>
          <p>
           4.1% (8/193)
          </p>
         </td>
         <td>
          <p>
           1.9% (3/159)
          </p>
         </td>
         <td>
          <p>
           0.3571
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kisukari ya ujauzito*
          </p>
         </td>
         <td>
          <p>
           1.0% (2/193)
          </p>
         </td>
         <td>
          <p>
           1.3% (2/158)
          </p>
         </td>
         <td>
          <p>
           1.0000
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Ujauzito wa kwanza*
          </p>
         </td>
         <td>
          <p>
           75.2% (167/222)
          </p>
         </td>
         <td>
          <p>
           47.2% (68/144)
          </p>
         </td>
         <td>
          <p>
           &lt;0.0001
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara wakati wa ujauzito*
          </p>
         </td>
         <td>
          <p>
           5.5% (12/220)
          </p>
         </td>
         <td>
          <p>
           7.7% (13/169)
          </p>
         </td>
         <td>
          <p>
           0.4086
           <sup>
            b
           </sup>
          </p>
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        Wachangiaji walichaguliwa katika vituo tofauti:
        <sup>
         1
        </sup>
        UZ Brussel, Ubelgiji,
        <sup>
         2
        </sup>
        Maastricht University Medical Center, Uholanzi na
        <sup>
         3
        </sup>
        Chuo cha Udaktari na Dawa, Vrije Universiteit Brussel, Ubelgiji.
        <sup>
         4
        </sup>
        Umri katika miaka.
       </p>
       <p>
        <italic>
         ART
        </italic>
        teknolojia za uzazi zinazosaidiwa,
        <italic>
         SC
        </italic>
        uzazi uliojitosheleza,
        <italic>
         SD
        </italic>
        wastani wa kihesabu,
        <italic>
         BMI
        </italic>
        viwango vya uzito wa mwili.
       </p>
       <p>
        *Pekee sehemu ya sampuli zilikuwa na data za kimatibabu kama vile umri wa mama, viwango vya uzito wa mwili vya mama (viwango vya uzito wa mwili), uzito wa kuzaliwa (uliovunjwa katika asilimia), umri wa ujauzito, jinsia, medium ya utamaduni, matatizo wakati wa ujauzito na uzazi. Medium ya UZB ilikuwa medium iliyoandaliwa ndani ya UZ Brussel. Watu wote ni watoto waliokomaa kutoka kwa upandikizaji wa mayai yaliyojitosheleza. Baadhi ya sifa hazikuwa za kutumika (NA) kwa sampuli fulani.
        <italic>
         N
        </italic>
        inaonyesha idadi ya sampuli ambazo data hii ilikuwa inapatikana. Majaribio ya takwimu ya pande mbili yalifanywa kwa kutumia jaribio la mwanafunzi t (
        <sup>
         a
        </sup>
        ) au jaribio la ukweli la Fisher (
        <sup>
         b
        </sup>
        ).
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
    <p id="Par9">
     Kwanza, data ilidhibitiwa kwa tofauti za usambazaji wa haplogroup. Hakuna tofauti muhimu zilizopatikana katika usambazaji wa haplogroup na subhaplogroup kati ya watoto wa ART na SC (Fig.
     <xref ref-type="fig" rid="Fig1">
      1b
     </xref>
     ,
     <xref ref-type="fig" rid="Fig1">
      c
     </xref>
     , na Meza za Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Karibu na haplogroup variants, watu wengi walibeba mabadiliko ya ziada ya homoplasmic, ambayo yaligawanywa kulingana na nafasi yao katika jeni ya mitochondrial na athari zake kwenye mfuatano wa asidi amino: eneo la mabadiliko ya haraka (HV), isiyo na maana, asili ya urudufishaji kwenye mfuatano mpana (OHR), mfuatano unaohusiana na kumalizia (TAS), rRNA, tRNA, sawa (Syn) na isiyo sawa (Non-syn) mabadiliko ya kuandika upya ya protein. Sehemu ya watu waliobeba mabadiliko ya homoplasmic ilikuwa sawa katika vikundi vyote viwili, pamoja na nafasi ya mabadiliko na uwezekano wao wa kuwa na madhara (Fig.
     <xref ref-type="fig" rid="Fig1">
      1d
     </xref>
     na Meza ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      3
     </xref>
     ). Mtu mmoja wa SC alibeba tofauti ya tRNA-coding yenye madhara yaliyothibitishwa kwa kiwango cha homoplasmic (mt.14674 T &gt; C, inayohusiana na Reversible Infantile Respiratory Chain Deficiency)
     <sup>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     .
    </p>
    <p id="Par10">
     Kwa jumla, mabadiliko 430 ya heteroplasmic yaligunduliwa, 66.0% ya ambayo yalikuwa ya kipekee kwa mtu mmoja (uelewa wa jumla umetolewa katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1e
     </xref>
     ). Kwa kuwa mabadiliko ya heteroplasmic yanaweza kutofautiana katika tishu tofauti na kuongezeka na umri, kwanza tulidhibiti seti ya data kwa ajili ya matumizi ya tishu tofauti kama chanzo cha DNA na umri tofauti wa uchukuzi. Hatukupata tofauti muhimu katika jumla ya mabadiliko ya heteroplasmic kwa kila mtu kwa kuzingatia chanzo cha DNA ya sampuli zao au umri wao wa uchukuzi (Fig.
     <xref ref-type="fig" rid="Fig1">
      1f
     </xref>
     ,
     <xref ref-type="fig" rid="Fig1">
      g
     </xref>
     ). Kisha, tuligawa mabadiliko ya heteroplasmic kwa kila nafasi, kama ilivyofanywa kwa mabadiliko ya homoplasmic. Asilimia 60.4 ya ART na 61.9% ya SC walibeba hadi mabadiliko 5 ya heteroplasmic kwa kila mtu, bila tofauti muhimu katika usambazaji wao (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     , Meza ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      4
     </xref>
     ). Pia hakukuwa na tofauti muhimu za takwimu katika usambazaji wa mabadiliko katika maeneo yasiyo na maana, tRNA, rRNA na mabadiliko sawa na isiyo sawa, ingawa watu wa ART mara nyingi walibeba mabadiliko ya kuandika upya ya protein isiyo sawa (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     , Meza ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      4
     </xref>
     )
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
      ,
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
      ,
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     .
    </p>
    <p id="Par11">
     Hakukuwa na tofauti katika usambazaji wa mabadiliko kulingana na nafasi zao, aina ya ubadilishaji wa nukleotidi na uwezekano wa kuwa na madhara (Fig.
     <xref ref-type="fig" rid="Fig1">
      1i
     </xref>
     , Meza za Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      5
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      6
     </xref>
     ). Watu wanne (3 wa ART na 1 wa SC) walibeba tofauti ya tRNA-coding yenye madhara yaliyothibitishwa, ikijumuisha mabadiliko ya m.3243 A &gt; G na m.5521 G &gt; A (zote mbili zinazohusiana na MELAS/MERRF syndrome), na m.5703 G &gt; A (inayohusiana na myopathy ya mitochondrial na MERRF). Ili kuhesabu mabadiliko ya heteroplasmic na kupunguza utata wa data kwa sababu ya nafasi mbalimbali za mabadiliko, tuliongeza mizigo ya mabadiliko ya heteroplasmic kwa kila mtu, zilizogawanywa kwa kila nafasi (HV, tRNA, n.k.). Hii ilisababisha matrix ya “jumla ya mizigo ya heteroplasmic” kwa kila mtu, kwa kila eneo. Watu wa ART na SC hawakutofautiana katika jumla ya wastani wa mizigo ya heteroplasmic kwa kila nafasi katika mtDNA zao (Fig.
     <xref ref-type="fig" rid="Fig1">
      1j
     </xref>
     , Meza ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      7
     </xref>
     ). Kisha, tulitumia uchanganuzi wa kuchunguza wa kugeuza kwa njia ya orthogonal kwenye jumla ya mizigo ya heteroplasmic ya kila nafasi katika mtDNA kwa kila mtu. Hii ilipunguza zaidi utata wa data hadi mambo manne; matrix ya kipengele inaweza kupatikana katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1k
     </xref>
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
      ,
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
      <xref ref-type="bibr" rid="CR69">
       69
      </xref>
     </sup>
     . Mambo haya yanawakilisha uhusiano kati ya aina za mabadiliko ya mtDNA, kama inavyowakilishwa na hypercube katika Fig.
     <xref ref-type="fig" rid="Fig1">
      1l
     </xref>
     <sup/>
     . Tulichukua alama za kila kipengele kwa sampuli zote na tukazitumia kuchunguza zaidi tofauti katika muundo wa mabadiliko ya heteroplasmic kati ya vikundi viwili. Watu wa ART walipatikana kuwa na alama za juu zaidi katika kipengele cha 2, kinachosukumwa na kuwepo kwa mabadiliko ya kuandika upya ya protein na rRNA na ukosefu wa mabadiliko ya HV, OHR, TAS na yasiyo na maana (Fig.
     <xref ref-type="fig" rid="Fig1">
      1m
     </xref>
     ). Mambo 1, 3 na 4 hayakutofautiana kati ya vikundi viwili. Hii inapendekeza kwamba watu waliozaliwa baada ya ART wanatendeka kuwa na mabadiliko ya heteroplasmic katika maeneo ya kuandika upya ya protein na/au rRNA, kwa pamoja na mabadiliko machache ya heteroplasmic katika maeneo mengine ikilinganishwa na watoto wao wa SC. Hii inalingana na (isivyofaa kiwango cha takwimu) mwelekeo wa watu wa ART kuwa na idadi kubwa ya mabadiliko isiyo sawa (Fig.
     <xref ref-type="fig" rid="Fig1">
      1h
     </xref>
     ) na mizigo ya chini ya wastani ya heteroplasmic katika eneo la HV (ART: 4.55%, SC: 7.02%, Fig.
     <xref ref-type="fig" rid="Fig1">
      1j
     </xref>
     ), na inaonyesha jinsi uchanganuzi wa kipengele unavyochukua mwingiliano muhimu kati ya vigezo ambavyo uchanganuzi wa kipekee haungeweza kugundua.
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     Tofauti katika muundo wa mabadiliko ya mtDNA yanahusiana na asilimia za uzito wa kuzaliwa
    </title>
    <p id="Par12">
     Tulichunguza uhusiano kati ya uzito wa kuzaliwa wa watu 388 na muundo wao wa mtDNA (164 SC na 224 ART). Uzito wa kuzaliwa uliwekwa sawa kwa umri wa ujauzito na jinsia na uligawanywa katika chini ya au juu ya percentile ya 10 (&lt;P10), ambapo &lt;P10 inachukuliwa kuwa ndogo kwa umri wa ujauzito, na chini ya au juu ya percentile ya 25 (&lt;P25).
    </p>
    <p id="Par13">
     Kwanza, tulichunguza dataset yetu kwa aina ambazo zimeonekana kuwa na uhusiano na uzito wa kuzaliwa
     <sup>
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     . Dataset yetu haikuwa na watu wanaobeba aina zilizotajwa katika marejeleo
     <sup>
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
     </sup>
     . Kuhusiana na aina m.16189T, ambayo imehusishwa na unyonge wakati wa kuzaliwa, watu 57 katika kundi letu la utafiti walibeba aina hii kama homoplasmy (mara nyingi kama sehemu ya kundi lao la damu) au kama heteroplasmy. Hata hivyo, haikuwa na uhusiano na uzito wa kuzaliwa chini ya percentile ya 10 au 25 katika kundi letu la utafiti (Data haijatolewa, jaribio la Chi-square,
     <italic>
      p
     </italic>
     = 1 na
     <italic>
      p
     </italic>
     = 0.851). Matokeo haya hayakubadilika kwa maana ikiwa tukizingatia aina hiyo tu wakati ilipo nje ya kundi la damu au kama heteroplasmy. Zaidi ya hayo, kundi la damu T, ambalo limehusishwa na uzito wa juu, linaonyesha mwelekeo wa kuwa limepunguzwa katika watu chini ya percentile ya 10 na 25 ya uzito wa kuzaliwa (
     <italic>
      p
     </italic>
     = 0.094 na
     <italic>
      p
     </italic>
     = 0.04, mtawalia, hata hivyo, maadili haya hayana maana baada ya urekebishaji wa Bonferroni kwa majaribio mengi, Fig.
     <xref ref-type="fig" rid="Fig2">
      2a
     </xref>
     ,
     <xref ref-type="fig" rid="Fig2">
      b
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      8
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      S9
     </xref>
     ). Hakukuwa na uhusiano kati ya makundi mengine ya damu na percentile ya uzito wa kuzaliwa wala na kuwepo kwa mabadiliko ya homoplasmy (Fig.
     <xref ref-type="fig" rid="Fig2">
      2c
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      10
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      11
     </xref>
     ), bila kujali njia ya kuzaliwa
     <sup>
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     .
     <fig id="Fig2" position="float">
      <label>
       Fig. 2
      </label>
      <caption xml:lang="sw">
       <title>
        Tofauti katika muundo wa variant za mtDNA zinahusiana na asilimia ya uzito wa kuzaliwa kwa watu waliozaliwa kwa njia ya asili.
       </title>
       <p>
        <bold>
         a
        </bold>
        ,
        <bold>
         b
        </bold>
        Hakuna tofauti muhimu katika upatikanaji wa haplogroups na subhaplogroups kati ya asilimia za uzito wa kuzaliwa, jaribio la Fisher’s exact lenye urekebishaji wa Bonferroni.
        <bold>
         c
        </bold>
        Hakuna tofauti muhimu katika asilimia ya watu wanaobeba variants homoplasmic katika maeneo tofauti na kulingana na asilimia ya uzito wa kuzaliwa, jaribio la Fisher’s exact lenye urekebishaji wa Bonferroni.
        <bold>
         d
        </bold>
        Alama za kipengele cha 2 kwa watoto waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa njia ya asili, zilizopangwa kulingana na asilimia ya uzito wa kuzaliwa. Jaribio la Mann–Whitney U lenye mwelekeo wa pande zote, *
        <italic>
         p
        </italic>
        = 0.04 na **
        <italic>
         p
        </italic>
        = 0.003,
        <italic>
         n
        </italic>
        uzazi uliofungamana na usaidizi wa kimatibabu &lt; P10 = 19,
        <italic>
         n
        </italic>
        uzazi uliofungamana na usaidizi wa kimatibabu &gt; P10 = 205,
        <italic>
         n
        </italic>
        waliokuzaliwa kwa njia ya asili &lt; P10 = 9,
        <italic>
         n
        </italic>
        waliokuzaliwa kwa njia ya asili &gt; P10 = 155,
        <italic>
         n
        </italic>
        uzazi uliofungamana na usaidizi wa kimatibabu &lt; P25 = 41,
        <italic>
         n
        </italic>
        uzazi uliofungamana na usaidizi wa kimatibabu &gt; P25 = 183,
        <italic>
         n
        </italic>
        waliokuzaliwa kwa njia ya asili &lt; P25 = 26,
        <italic>
         n
        </italic>
        waliokuzaliwa kwa njia ya asili &gt; P25 = 138 watu.
        <bold>
         e
        </bold>
        Uzito wa variants za heteroplasmic za tRNA, rRNA, na za kuamsha protein zinazofanana (Syn) na zisizo za maana (Non-syn) zilizopatikana kwa watu waliozaliwa kwa njia ya asili na wale waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu, zilizopangwa kulingana na asilimia ya uzito wa kuzaliwa. Jaribio la Mann–Whitney U lenye mwelekeo wa pande zote, kwa variants za rRNA &lt;P10 **
        <italic>
         p
        </italic>
        = 0.01, &lt;P25 **
        <italic>
         p
        </italic>
        = 0.007, kwa variants zisizo za maana &lt;P10
        <italic>
         p
        </italic>
        = 0.067, &lt;P25 *
        <italic>
         p
        </italic>
        = 0.034 na kwa variants zisizo za maana na za rRNA zilizounganishwa, * kwa &lt;P10
        <italic>
         p
        </italic>
        = 0.011, &lt;P25 ***
        <italic>
         p
        </italic>
        = 0.001.
        <bold>
         f
        </bold>
        ,
        <bold>
         g
        </bold>
        Idadi ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa njia ya asili, waliopangwa kwa kujitegemea kwa kuzingatia jinsia na asilimia ya uzito wa kuzaliwa chini ya au juu ya P10 au P25, mtawalia, wanaobeba variants za rRNA na za kuamsha protein zisizo za maana. Wanawake waliozaliwa kwa njia ya asili &lt;P25 wana kiwango cha juu zaidi cha variants za rRNA na za kuamsha protein zisizo za maana (* jaribio la Fisher’s exact lenye mwelekeo wa pande zote,
        <italic>
         p
        </italic>
        = 0.012).
        <bold>
         h
        </bold>
        Asilimia ya watu waliozaliwa kwa njia ya asili na wale waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu wanaopatikana chini ya au juu ya P25 na wanaobeba variants za rRNA na za kuamsha protein zisizo za maana, zilizopangwa kwa kujitegemea kwa kuzingatia jinsia na kwa kuzingatia mazingira ya utamaduni wa mayai. Mistari ya wima katika sehemu (
        <bold>
         d
        </bold>
        ) na (
        <bold>
         e
        </bold>
        ) inawakilisha wastani wa thamani katika grafu ya nukta, kila nukta inawakilisha sampuli. Data ya chanzo imetolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig2_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
    <p id="Par14">
     Kinyume chake, watu wa SC ambao walikuwa na uzito wa kuzaliwa chini ya percentile ya 10 au 25 walikuwa na alama za juu zaidi katika sababu ya 2 ya uchambuzi wa mabadiliko ya heteroplasmy kuliko watoto waliozaliwa na uzito wa juu zaidi ya percentile ya 10 au 25 (Fig.
     <xref ref-type="fig" rid="Fig2">
      2d
     </xref>
     ). Kwa mujibu wa hayo, kwa kuwa sababu ya 2 inasukumwa na mabadiliko ya rRNA na yasiyo ya maana, watu wa SC wenye uzito wa kuzaliwa wa chini mara nyingi walibeba mabadiliko ya yasiyo ya maana na rRNA, wakati hakukuwa na tofauti zilizopimwa kwa aina nyinginezo (&lt;P10: 66.6% na &gt;P10: 25.2%, jaribio la Fisher’s exact,
     <italic>
      p
     </italic>
     = 0.014, &lt;P25: 53.8% na &gt;P25: 22.5%, jaribio la Fisher’s exact,
     <italic>
      p
     </italic>
     = 0.003, Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      12
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      13
     </xref>
     ). Watoto wa SC walio na uzito wa kuzaliwa chini ya percentile ya 10 au 25 pia walikuwa na mabadiliko ya juu zaidi ya rRNA (Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ), ya mabadiliko yasiyo ya maana (Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ) na ya mabadiliko yasiyo ya maana na rRNA kwa pamoja (&lt;P10
     <italic>
      p
     </italic>
     = 0.011, &lt;P25
     <italic>
      p
     </italic>
     = 0.001, Fig.
     <xref ref-type="fig" rid="Fig2">
      2e
     </xref>
     ). Kwa ujasiri, tofauti hizi hazikuonekana katika watu wa ART (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      14
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      15
     </xref>
     ). Ili kubainisha ni vigeu gani vingine vinavyoweza kuathiri matokeo, kwanza tuligawanya sampuli kwa ajili ya jinsia (Fig.
     <xref ref-type="fig" rid="Fig2">
      2f
     </xref>
     ,
     <xref ref-type="fig" rid="Fig2">
      g
     </xref>
     ). Mgawanyiko huu ulisababisha &lt;P25 wa kike wa SC kuwa na kiwango cha juu zaidi cha mabadiliko yasiyo ya maana na rRNA (
     <italic>
      p
     </italic>
     = 0.012), wakati wa kiume wa SC &lt;P25 na wa kike wa SC na wa kiume &lt;P10 walionyesha viwango vya juu zaidi na maadili ya
     <italic>
      p
     </italic>
     ya 0.098, 0.087 na 0.093, mtawalia. Katika kundi la ART, tu &lt;P25 wa kike wa ART walikuwa na viwango vya juu lakini visivyo na maana vya mabadiliko yasiyo ya maana na rRNA (
     <italic>
      p
     </italic>
     = 0.2075, Fig.
     <xref ref-type="fig" rid="Fig2">
      2
     </xref>
     f,
     <xref ref-type="fig" rid="Fig2">
      g
     </xref>
     ). Kigezo kingine kinachowezekana katika kundi letu ni vifaa mbalimbali vya utunzaji wa mayai ambavyo mayai yalikuwa yakipitishwa. Kundi letu la utafiti linaingiliana kwa kiasi kikubwa na la utafiti ulioonyesha kwamba mayai yaliyokuzwa katika mazingira ya Cook® yana uzito wa kuzaliwa wa chini, na kwamba mayai ya kiume ni nyeti zaidi kwa athari hii
     <sup>
      <xref ref-type="bibr" rid="CR70">
       70
      </xref>
     </sup>
     . Tunashuhudia mwelekeo sawa katika utafiti huu, ambapo kwa watu ambao walipitishwa katika mazingira ya Cook® na UZB (yaani, mazingira ya ndani yaliyofanywa katika UZ Brussel) wa kiume wana uzito wa kuzaliwa chini ya percentile ya 25 zaidi ya wa kike (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     , 25.5% kati ya wa kiume dhidi ya 10.7% kati ya wa kike,
     <italic>
      p
     </italic>
     = 0.0745). Zaidi ya hayo, tu mmoja wa &lt;P25 wa kiume wa ART (5%) alibeba mabadiliko yasiyo ya maana au rRNA, ikilinganishwa na 53.8% ya &lt;P25 wa SC (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     ,
     <italic>
      p
     </italic>
     = 0.001). Kinyume chake, watu walioathiriwa na mazingira ya Vitrolife® walibeba mabadiliko yasiyo ya maana na rRNA katika kesi 50%, kwa njia sawa na &lt;P25 wa SC (Fig.
     <xref ref-type="fig" rid="Fig2">
      2h
     </xref>
     ). Matokeo haya yanapendekeza kwamba athari ya mazingira ya Cook® au UZB inazidi athari yoyote ya mabadiliko ya mtDNA. Kwa hiyo, katika uchanganuzi zaidi, tuliondoa watu wa ART walioathiriwa na mazingira ya Cook® na UZB na tulichambua upya mambo yote yanayohusiana na mtDNA kwa watu wa SC na ART walioathiriwa na mazingira ya Vitrolife® pekee. Hakukuwa na uhusiano kati ya kundi la damu (au kundi la damu la chini) na percentile ya uzito wa kuzaliwa (Fig.
     <xref ref-type="fig" rid="Fig3">
      3a
     </xref>
     ,
     <xref ref-type="fig" rid="Fig3">
      b
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      16
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      17
     </xref>
     ) wala na kuwepo kwa mabadiliko ya homoplasmy, isipokuwa mabadiliko ya tRNA, ambayo yalikuwa ya kawaida zaidi katika watu walio na uzito wa kuzaliwa chini ya percentile ya 10 (29.4% dhidi ya 6.4%, Fig.
     <xref ref-type="fig" rid="Fig3">
      3c
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      18
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      19
     </xref>
     ). Wakati wa kuchunguza mabadiliko ya heteroplasmy, &lt;P25 na &lt;P10 walikuwa na mabadiliko ya yasiyo ya maana ya utungaji wa protini na rRNA, lakini tu yakafikia umuhimu wa kiwanja kwa mabadiliko yasiyo ya maana katika &lt;P25 (Fig.
     <xref ref-type="fig" rid="Fig3">
      3d
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      20
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      21
     </xref>
     ). Kwa kuwa katika kesi nyingi mabadiliko yasiyo ya maana hayakujulikana kuwa na uhusiano na ugonjwa wa mitochondrial, tuligawanya katika kundi la kuwa na ushahidi wa ziada wa uwezekano wao wa kuwa na madhara. Mabadiliko 15 (18.75%) yalikuwa na alama ya MutPred2 zaidi ya 0.61 na mabadiliko 46 (57.7%) yalikuwa na kiwango kilichoripotiwa cha chini ya 0.002 katika MITOMAP (mitomap.org), ambayo imependekezwa kama ushahidi wa kuunga mkono uwezekano wa kuwa na madhara
     <sup>
      <xref ref-type="bibr" rid="CR71">
       71
      </xref>
      <xref ref-type="bibr" rid="CR72">
       72
      </xref>
      <xref ref-type="bibr" rid="CR73">
       73
      </xref>
     </sup>
     . Uwiano huu wa mabadiliko usio wa kawaida katika idadi yetu ni mkubwa zaidi kuliko ile iliyopatikana katika database ya MITOMAP, ambapo 19% ya mabadiliko yanakidhi ufunguo huu
     <sup>
      <xref ref-type="bibr" rid="CR73">
       73
      </xref>
     </sup>
     . Kwa kuchukua pamoja alama za MutPred2 na viwango vya MITOMAP, mabadiliko 50 kati ya 80 yaliyobainishwa ya yasiyo ya maana yana ushahidi wa kuunga mkono uwezekano wao wa kuwa na madhara (62.5%, Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM4">
      1
     </xref>
     ). Ulinganisho wa uwiano wao katika watu chini ya na zaidi ya P25 haikuonyesha tofauti za umuhimu wa kimwili, kwa sababu ya saizi ndogo ya sampuli (21% katika &lt;P25, 14% katika &gt;P25, jaribio la Fisher’s exact,
     <italic>
      p
     </italic>
     = 0.270), na hatukuchambua zaidi mgawanyiko huu wa mabadiliko katika uchambuzi unaofuata. Kuchanganya mabadiliko yasiyo ya maana na rRNA inaonyesha kwamba 52.9% ya &lt;P10 na 52.1% ya &lt;P25 wana angalau moja ya mabadiliko hayo (dhidi ya &gt;P10: 31.3% na &gt;P25: 28.6%, Fig.
     <xref ref-type="fig" rid="Fig3">
      3e
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      20
     </xref>
     na
     <xref ref-type="supplementary-material" rid="MOESM1">
      21
     </xref>
     ). Zaidi ya hayo, watu wa SC na wa ART walioathiriwa na mazingira ya Vitrolife® wenye uzito wa kuzaliwa chini ya percentile ya 10 au 25 walikuwa na mabadiliko ya juu zaidi ya jumla ya mabadiliko yasiyo ya maana na rRNA (Fig.
     <xref ref-type="fig" rid="Fig3">
      3f
     </xref>
     ).
     <fig id="Fig3" position="float">
      <label>
       Fig. 3
      </label>
      <caption xml:lang="sw">
       <title>
        Watoto waliozaliwa bila kuungwa mkono na uzazi wa asili na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife yana uwezekano mkubwa wa kuwa na mabadiliko ya non-synonymous na rRNA.
       </title>
       <p>
        <bold>
         a
        </bold>
        ,
        <bold>
         b
        </bold>
        Ushiriki wa vikundi vya damu na vikundi vidogo vya damu, kwa mtiririko huo, kati ya watu waliozaliwa bila kuungwa mkono na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife, waliovunjwa kulingana na asilimia ya uzito wa kuzaliwa. Jaribio la Fisher-exact la pande mbili, hakuna tofauti muhimu zilizopatikana baada ya marekebisho ya Bonferroni (
        <italic>
         p
        </italic>
        values ≤ 0.007 zilichukuliwa kuwa muhimu).
        <bold>
         c
        </bold>
        Asilimia ya watu waliozaliwa bila kuungwa mkono na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife wanaobeba mabadiliko ya homoplasmic katika maeneo tofauti na waliovunjwa kulingana na asilimia ya uzito wa kuzaliwa. Mabadiliko ya homoplasmic katika maeneo ya tRNA yalipatikana mara kwa mara zaidi kwa watoto waliozaliwa na uzito wa chini &lt;P10 (29.4% vs 6.4%, jaribio la Fisher-exact la pande mbili na marekebisho ya Bonferroni,
        <italic>
         p
        </italic>
        = 0.006 (
        <italic>
         p
        </italic>
        values ≤ 0.00625 zilichukuliwa kuwa muhimu)).
        <bold>
         d
        </bold>
        Idadi ya watu waliozaliwa bila kuungwa mkono na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife, waliovunjwa kulingana na asilimia ya uzito wa kuzaliwa chini ya au juu ya P10 au P25, wanaobeba mabadiliko ya non-synonymous ya maandishi ya protein-coding au rRNA loci. Watoto waliozaliwa na uzito wa chini &lt;P25 mara nyingi walibeba mabadiliko ya non-synonymous ya maandishi ya protein-coding (37.5% vs 29.5%, jaribio la Fisher-exact la pande mbili, *
        <italic>
         p
        </italic>
        = 0.015).
        <bold>
         e
        </bold>
        Idadi ya watu waliozaliwa bila kuungwa mkono na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife, waliovunjwa kulingana na asilimia ya uzito wa kuzaliwa chini ya au juu ya P10 au P25, wanaobeba mabadiliko ya non-synonymous ya maandishi ya protein-coding na/or rRNA loci. 52.9% ya &lt;P10 na 52.1% ya &lt;P25 ya watu waliozaliwa na uzito wa chini wana angalau moja ya mabadiliko hayo (vs &gt;P10: 31.3%, jaribio la Fisher-exact la pande mbili,
        <italic>
         p
        </italic>
        = 0.106, &gt;P25: 28.6%, jaribio la Fisher-exact, **
        <italic>
         p
        </italic>
        = 0.002).
        <bold>
         f
        </bold>
        Jumla ya mabadiliko ya heteroplasmic ya watu waliozaliwa bila kuungwa mkono na wale waliopata uzazi wa kuungwa mkono ambao wamejishughulisha na mazingira ya Vitrolife chini ya au juu ya P10 na P25, wanaobeba mabadiliko ya non-synonymous ya maandishi ya protein-coding na rRNA. &lt;P10 na &lt;P25 walikuwa na jumla kubwa ya mabadiliko ya heteroplasmic ya non-synonymous na rRNA (jaribio la Mann-Whitney U la pande mbili,
        <italic>
         p
        </italic>
        = 0.077 na **
        <italic>
         p
        </italic>
        = 0.003, kwa mtiririko huo).
        <italic>
         n
        </italic>
        &lt; P10 = 17 watu,
        <italic>
         n
        </italic>
        &gt; P10 = 265 watu,
        <italic>
         n
        </italic>
        &lt; P25 = 48 watu,
        <italic>
         n
        </italic>
        &gt; P25 = 234 watu. Mistari ya wima katika sehemu zinawakilisha wastani wa thamani katika grafu ya scatter, kila nukta inawakilisha sampuli. # thamani muhimu ya
        <italic>
         p
        </italic>
        baada ya marekebisho ya Bonferroni, +
        <italic>
         p
        </italic>
        &lt; 0.2, iliyochaguliwa kwa ajili ya regression ya binary logistic ya hali ya kufata. Data ya chanzo zinatolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig3_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
    <p id="Par15">
     Kisha, tulitumia regression ya kimwili ya binary ili kuchunguza athari ya vigeu tofauti vinavyohusiana na mtDNA kwenye uzito wa kuzaliwa, ikijumuisha vigeu vinavyoweza kuathiri matokeo vilivyoorodheshwa katika Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     <sup/>
     . Tulitumia mbinu mbili: kwanza, tulijumuisha kigezo chochote cha mtDNA ambacho kilikuwa na uhusiano na percentile ya uzito wa kuzaliwa kupitia uchanganuzi wa kipekee na
     <italic>
      p
     </italic>
     &lt; 0.2 katika muundo, isipokuwa kuwepo kwa mabadiliko ya TAS ya homoplasmy kwa sababu yalikuwa yanapatikana katika watu 3 pekee katika kundi letu la utafiti (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM5">
      2
     </xref>
     ). Pili, tulijaribu mbinu ya hali ya nyuma, ambapo tulipitisha vigeu vyote vilivyoorodheshwa katika Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM5">
      2
     </xref>
     <sup/>
     . Kwa watu walio na uzito wa kuzaliwa chini ya percentile ya 10, vigeu vifuatavyo vilikuwa na athari ya umuhimu wa kimwili kwenye uzito wa kuzaliwa: kuvuta sigara wakati wa ujauzito, shinikizo la damu wakati wa ujauzito, kuwepo kwa mabadiliko ya tRNA ya homoplasmy nje ya kundi la damu la mtu, na kuwepo kwa mabadiliko yanayohusiana na kundi la damu K1 (Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ). Vigeu hivyo hivyo pia vilipatikana kuwa na uhusiano mkubwa na uzito wa kuzaliwa, isipokuwa na mabadiliko yanayohusiana na kundi la damu K1 (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      22
     </xref>
     ). Katika kesi ya watu walio na uzito wa kuzaliwa chini ya percentile ya 25, regression ya kimwili ilisababisha muundo unaojumuisha makundi ya damu I, J na T, umri wa mama, kuwepo kwa mabadiliko ya tRNA ya homoplasmy nje ya kundi la damu la mtu, na kuwepo kwa mabadiliko ya heteroplasmy ya yasiyo ya maana na rRNA. Tu kundi la damu I, umri wa mama, na kuwepo kwa mabadiliko ya heteroplasmy ya yasiyo ya maana na rRNA yalikuwa na athari ya umuhimu wa kimwili katika kuongeza uwezekano wa kuzaliwa na uzito chini ya percentile ya 25 (Jedwali
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ). Muundo wa hali ya nyuma ulihifadhi umri wa mama na kuwepo kwa mabadiliko ya heteroplasmy ya yasiyo ya maana na rRNA kama yanayohusiana kwa umuhimu na uzito wa kuzaliwa chini ya percentile ya 25 (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      23
     </xref>
     ). Ingawa regression ya kimwili ilibainisha vigeu ambavyo vilikuwa na athari ya umuhimu wa kimwili kwenye utabiri wa percentile ya uzito wa kuzaliwa, muundo ulioundwa na regression haukuwa na ufanisi katika kutabiri kama mtu angekuwa na uzito wa kuzaliwa chini ya percentile ya 10 au 25. Katika kundi la &lt;P10, tu mtu 1 kati ya 13 alibainishwa kwa usahihi, wakati katika kundi la &lt;P25, kulikuwa na watu 4 kati ya 42. Kwa hiyo, tulibuni muundo mwingine kulingana na mbinu ya uchambuzi wa kibaguzi. Tulijenga miundo mitatu: ya kwanza iliyotumia vigeu vya ujauzito pekee (umri wa mama, kuvuta sigara, shinikizo la damu wakati wa ujauzito, BMI ya mama &gt;25, uzazi wa kwanza na ujauzito wa kisukari), ya pili iliyotumia vigeu vya mtDNA pekee vinavyohusiana na matokeo ya percentile ya uzito wa kuzaliwa na
     <italic>
      p
     </italic>
     &lt; 0.2, na muundo wa tatu uliojumuisha vyote viwili (Jedwali
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     na
     <xref ref-type="table" rid="Tab4">
      4
     </xref>
     ). Miundo ya kutabiri &lt;P10 na &lt;P25 ilionyesha kwamba, wakati vigeu vya ujauzito pekee vilikuwa vizuri katika kutabiri percentile ya uzito wa kuzaliwa, kuongeza vigeu vya mtDNA kuliongeza uwezo wa muundo wa kutambua kwa usahihi watu walio na uzito wa kuzaliwa chini ya percentile ya 10 na 25. Kwa muundo wa &lt;P10, kuongeza vigeu vya mtDNA kuliongeza kwa kiasi kikubwa usahihi wa kutambua watu walio na uzito wa kuzaliwa chini ya percentile ya 10 kutoka 40% hadi 70%. Kwa &lt;P25, usahihi uliongezeka kwa kiwango cha wastani zaidi kutoka 58.1% hadi 67.7%. Kwa ujasiri, vigeu vya mtDNA pekee vilikuwa na nguvu zaidi ya kutabiri uzito wa kuzaliwa chini ya percentile ya 25 kuliko vigeu vya ujauzito (64.9% dhidi ya 62.5% ya utambuzi sahihi, mtawalia).
     <table-wrap id="Tab2">
      <label>
       Table 2
      </label>
      <caption xml:lang="en">
       <p>
        Uchanganuzi wa kimatibabu wa kukadiria uzito wa kuzaliwa chini ya percentile ya 10 au 25 katika watu wa SC na ART waliojishughulisha na medium ya Vitrolife
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           Exp(B)
          </p>
         </th>
         <th>
          <p>
           95% C.I. kwa Exp(B)
          </p>
         </th>
         <th>
          <p>
           Maana
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            P10 katika SC na ART Vitrolife
           </bold>
           ®
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara
          </p>
         </td>
         <td>
          <p>
           7.211
          </p>
         </td>
         <td>
          <p>
           1.552–33.496
          </p>
         </td>
         <td>
          <p>
           0.012
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Magonjwa ya ujauzito
          </p>
         </td>
         <td>
          <p>
           14.045
          </p>
         </td>
         <td>
          <p>
           1.185–166.410
          </p>
         </td>
         <td>
          <p>
           0.036
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kundi la haplogroup K1
          </p>
         </td>
         <td>
          <p>
           4.952
          </p>
         </td>
         <td>
          <p>
           1.075–22.813
          </p>
         </td>
         <td>
          <p>
           0.040
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Homoplasmies za tRNA
          </p>
         </td>
         <td>
          <p>
           7.518
          </p>
         </td>
         <td>
          <p>
           1.850–30.553
          </p>
         </td>
         <td>
          <p>
           0.005
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko ya heteroplasmic isiyo na maana na rRNA
          </p>
         </td>
         <td>
          <p>
           2.180
          </p>
         </td>
         <td>
          <p>
           642–7.400
          </p>
         </td>
         <td>
          <p>
           0.212
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            P25 katika SC na ART Vitrolife
           </bold>
           ®
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           1.129
          </p>
         </td>
         <td>
          <p>
           1.036–1.231
          </p>
         </td>
         <td>
          <p>
           0.006
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kundi la haplogroup I
          </p>
         </td>
         <td>
          <p>
           5.774
          </p>
         </td>
         <td>
          <p>
           1.125–29.624
          </p>
         </td>
         <td>
          <p>
           0.035
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kundi la haplogroup J
          </p>
         </td>
         <td>
          <p>
           2.248
          </p>
         </td>
         <td>
          <p>
           0.783–6.455
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kundi la haplogroup T
          </p>
         </td>
         <td>
          <p>
           0.146
          </p>
         </td>
         <td>
          <p>
           0.018–1.165
          </p>
         </td>
         <td>
          <p>
           0.069
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Homoplasmies za tRNA
          </p>
         </td>
         <td>
          <p>
           2.405
          </p>
         </td>
         <td>
          <p>
           0.796–7.264
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Mabadiliko ya heteroplasmic isiyo na maana na rRNA
          </p>
         </td>
         <td>
          <p>
           2.974
          </p>
         </td>
         <td>
          <p>
           1.439–6.2144
          </p>
         </td>
         <td>
          <p>
           0.003
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="Tab3">
      <label>
       Table 3
      </label>
      <caption xml:lang="en">
       <p>
        Uchambuzi wa kubainisha tofauti ili kubashiri uzito wa kuzaliwa chini ya percentile ya 10 kwa watu binafsi wa SC na ART wanaotumia utamaduni wa Vitrolife®
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th>
          <p>
           Vigezo vilivyotumika katika muundo
          </p>
         </th>
         <th colspan="2">
          <p>
           Vigezo vya chaguo za kukokotoa vya kubainisha tofauti vilivyosawazishwa
          </p>
         </th>
         <th>
          <p>
           Lambda ya Wilks
          </p>
          <p>
           <italic>
            N
           </italic>
           = idadi ya kesi zilizotumika katika muundo
          </p>
         </th>
         <th>
          <p>
           Imetambuliwa kwa usahihi (kundi la asili dhidi ya kundi lililothibitishwa)
          </p>
          <p>
           Imetambuliwa kwa usahihi katika kila kundi
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td rowspan="6">
          <p>
           Vigezo vyote vya ujauzito
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.249
          </p>
         </td>
         <td rowspan="6">
          <p>
           <italic>
            P
           </italic>
           = 0.010
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="6">
          <p>
           89.0% vs 87.0%
          </p>
          <p>
           90.5% &gt;P10 sahihi
          </p>
          <p>
           40%
           <P10/>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara
          </p>
         </td>
         <td>
          <p>
           0.756
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shida za ujauzito
          </p>
         </td>
         <td>
          <p>
           0.596
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Maternal BMI &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.509
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Ukoma wa ujauzito
          </p>
         </td>
         <td>
          <p>
           0.001
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="3">
          <p>
           Vigezo vya mtDNA pekee
          </p>
         </td>
         <td>
          <p>
           Vigeu vya tRNA vya homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.817
          </p>
         </td>
         <td rowspan="3">
          <p>
           <italic>
            P
           </italic>
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
     <table-wrap id="Tab4">
      <label>
       Table 4
      </label>
      <caption xml:lang="en">
       <p>
        Uchambuzi wa kubainisha tofauti ili kubashiri uzito wa kuzaliwa chini ya percentile ya 25 kwa watu binafsi wa SC na ART wanaotumia utamaduni wa Vitrolife®
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th>
          <p>
           Vigezo vilivyotumika katika muundo
          </p>
         </th>
         <th colspan="2">
          <p>
           Vigezo vya chaguo za kukokotoa vya kubainisha tofauti vilivyosawazishwa
          </p>
         </th>
         <th>
          <p>
           Lambda ya Wilks
          </p>
          <p>
           <italic>
            N
           </italic>
           = idadi ya kesi zilizotumika katika muundo
          </p>
         </th>
         <th>
          <p>
           Imetambuliwa kwa usahihi (kundi la asili dhidi ya kundi lililothibitishwa)
          </p>
          <p>
           Imetambuliwa kwa usahihi katika kila kundi
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td rowspan="6">
          <p>
           Vigezo vyote vya ujauzito
          </p>
         </td>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.871
          </p>
         </td>
         <td rowspan="6">
          <p>
           <italic>
            P
           </italic>
           = 0.174
          </p>
          <p>
           <italic>
            N
           </italic>
           = 200
          </p>
         </td>
         <td rowspan="6">
          <p>
           62.5% vs 59.5%
          </p>
          <p>
           63.3% &gt;P25 sahihi
          </p>
          <p>
           58.1%
           <P25/>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Kuvuta sigara
          </p>
         </td>
         <td>
          <p>
           0.412
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Shida za ujauzito
          </p>
         </td>
         <td>
          <p>
           0.392
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Maternal BMI &gt; 25
          </p>
         </td>
         <td>
          <p>
           −0.109
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Primiparity
          </p>
         </td>
         <td>
          <p>
           0.132
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Ukoma wa ujauzito
          </p>
         </td>
         <td>
          <p>
           −0.093
          </p>
         </td>
        </tr>
        <tr>
         <td rowspan="5">
          <p>
           Vigezo vya mtDNA pekee
          </p>
         </td>
         <td>
          <p>
           Vigeu vya tRNA vya homoplasmic
          </p>
         </td>
         <td>
          <p>
           0.369
          </p>
         </td>
         <td rowspan="5">
          <p>
           <italic>
            P
           </italic>
          </p>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     Watoto walirozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu mara nyingi huchukua mabadiliko mapya ya non-synonymous ikilinganishwa na wenzao walirozaliwa kwa njia asilia
    </title>
    <p id="Par16">
     Ili kuchunguza asili ya tofauti hizi katika mtDNA, tulichunguza jeni ya mitochondrial ya jozi 67 za mama na mtoto wa ART na 90 za SC. Tuligawa mabadiliko kama “yaliyopitishwa” wakati yalipokuwa yakipatikana katika mama na mtoto, na kama “de novo” wakati mabadiliko hayo yalipokuwa yakipatikana tu katika mtoto. Kwa jumla, tulipata mabadiliko 19 yaliyopitishwa, na mabadiliko ya jumla katika mabadiliko ya heteroplasmy ambayo hayakupatikana tofauti kati ya watu wa SC na ART (Fig.
     <xref ref-type="fig" rid="Fig4">
      4a
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      24
     </xref>
     ), na mabadiliko 109 de novo, 36 kati yao yakiwa katika maeneo yasiyo na maana, 54 katika maeneo ya utungaji wa protini, 8 katika rRNA na 11 katika maeneo ya tRNA (Fig.
     <xref ref-type="fig" rid="Fig4">
      4b
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM6">
      3
     </xref>
     ). Jozi za mama na mtoto wa ART zilikuwa na kiwango cha juu zaidi cha mabadiliko de novo yasiyo ya maana kuliko jozi za mama na mtoto wa SC (ART: 38.8% (26/67), SC: 20.0% (18/90), Fig.
     <xref ref-type="fig" rid="Fig4">
      4c
     </xref>
     ). Kwa mujibu wa hayo, wakati hakukuwa na tofauti katika jumla ya mabadiliko ya heteroplasmy ya mabadiliko yaliyopitishwa kwa kila mtu (Fig.
     <xref ref-type="fig" rid="Fig4">
      4a
     </xref>
     ), watoto wa ART walikuwa na mabadiliko ya juu zaidi ya mabadiliko de novo yasiyo ya maana (Fig.
     <xref ref-type="fig" rid="Fig4">
      4d
     </xref>
     ). Matokeo haya yanapendekeza kwamba tofauti katika mabadiliko ya mtDNA kati ya watoto wa ART na SC zinatokana na kupatikana kwa wingi zaidi kwa mabadiliko de novo yasiyo ya maana katika watoto wa ART.
     <fig id="Fig4" position="float">
      <label>
       Fig. 4
      </label>
      <caption xml:lang="sw">
       <title>
        Watu waliozaliwa baada ya uzazi wa kuungwa mkono wana uwezekano mkubwa wa kuwa na mabadiliko ya de novo ya mtDNA ya non-synonymous kuliko wale waliozaliwa bila kuungwa mkono.
       </title>
       <p>
        <bold>
         a
        </bold>
        Muhtasari wa mabadiliko ya heteroplasmic yaliyopitishwa ambayo yalipatikana katika jozi za mama na mtoto, zilizovunjwa kulingana na aina ya uzazi na zilizoandikwa kulingana na nafasi yake katika jeni ya mtDNA. Ukubwa wa duara ni sawia na mabadiliko ya heteroplasmic katika mama na mtoto wake. Hakuna tofauti muhimu za takwimu kati ya SC na ART, jaribio la Mann-Whitney U la pande mbili.
        <bold>
         b
        </bold>
        Muhtasari wa mabadiliko ya heteroplasmic ya de novo ambayo yalipatikana katika jozi za mama na mtoto, zilizovunjwa kulingana na aina ya uzazi na zilizoandikwa kulingana na nafasi yake katika jeni ya mtDNA. Ukubwa wa duara ni sawia na mabadiliko ya heteroplasmic katika mtoto.
        <bold>
         c
        </bold>
        Idadi ya jozi za mama na mtoto za ART na SC zinazoonyesha mabadiliko ya de novo ya non-synonymous na rRNA. Watoto waliozaliwa baada ya uzazi wa kuungwa mkono mara nyingi wanaonyesha mabadiliko ya de novo ya protein-coding zaidi kuliko wale waliozaliwa bila kuungwa mkono (jaribio la Fisher-exact la pande mbili, *
        <italic>
         p
        </italic>
        = 0.01).
        <bold>
         d
        </bold>
        Jumla ya mabadiliko ya heteroplasmic ya mabadiliko ya de novo katika watu waliozaliwa baada ya uzazi wa kuungwa mkono na wale waliozaliwa bila kuungwa mkono, zilizovunjwa kwa kila eneo. Jaribio la Mann-Whitney U la pande mbili *
        <italic>
         p
        </italic>
        = 0.048,
        <italic>
         n
        </italic>
        ART = 67 watu,
        <italic>
         n
        </italic>
        SC = 90 watu. Mistari ya wima inawakilisha wastani wa thamani katika grafu ya scatter, kila nukta inawakilisha sampuli. Data ya chanzo zinatolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig4_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
   </sec>
   <sec id="Sec6">
    <title>
     Umri wa mama na ukubwa wa kundi la mayai baada ya OS yanahusiana chanya na ongezeko la mabadiliko mapya ya mtDNA kwa watoto na mayai
    </title>
    <p id="Par17">
     Tulidhania kwamba utaratibu wa ART unaohusiana na OS unaweza kuwa na sababu ya tofauti katika mabadiliko de novo ambayo yalipatikana kati ya jozi za mama na mtoto wa ART na SC. Ili kujaribu hili, tulilinganisha jeni ya mitochondrial ya mayai ya ndugu ambayo yalipatikana kutoka kwa mizunguko ya kawaida ya mwezi au baada ya OS kutoka kwa wanawake 29 wajawazito (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      25
     </xref>
     ). Tulipitia sehemu kubwa ya mtDNA (12.9 Kbp) ya mayai 113 ya kibinafsi, 48 kutoka kwa mizunguko ya kawaida na 65 kutoka kwa mizunguko ya OS, pamoja na vyanzo vitatu vya DNA ya somatic kutoka kwa watoa huduma. Hii iliruhusu sisi kugawa mabadiliko ya heteroplasmy kama yaliyopitishwa (yaliyopatikana katika angalau sampuli mbili za mtoa huduma mmoja, Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM7">
      4
     </xref>
     ) au de novo (pekee katika yai moja, Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM8">
      5
     </xref>
     ).
    </p>
    <p id="Par18">
     Aina kumi na nne za vigezo vilivyopitishwa viligunduliwa katika mayai ya wanandoa saba. Hakuna mwelekeo ulioonekana katika mabadiliko ya mizigo ya vigezo sawa katika mayai yaliyopatikana baada ya mzunguko wa asili na baada ya mzunguko wa OS (Fig.
     <xref ref-type="fig" rid="Fig5">
      5a
     </xref>
     , Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM7">
      4
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      26
     </xref>
     ).
     <fig id="Fig5" position="float">
      <label>
       Fig. 5
      </label>
      <caption xml:lang="sw">
       <title>
        Uzee wa mama na ukubwa wa kikundi cha mayai baada ya OS hubainisha uwezekano mkubwa wa kuwa na mabadiliko ya de novo ya mtDNA katika watoto na mayai.
       </title>
       <p>
        <bold>
         a
        </bold>
        Mabadiliko ya heteroplasmic yaliyopitishwa ambayo yalipatikana katika wazazi wa mayai na mayai yao. Ukubwa wa duara ni sawia na mabadiliko ya heteroplasmic ya mabadiliko katika kila sampuli, ambayo inajumuisha tishu za kimwili na hadi mayai 3 katika mzunguko wa asili na hadi mayai 7 baada ya OS.
        <bold>
         b
        </bold>
        Usambazaji wa idadi ya mayai baada ya mizunguko ya asili na OS inayoonyesha mabadiliko ya de novo katika maeneo tofauti. Hakuna tofauti muhimu za takwimu zilizopatikana (jaribio la Chi-square la pande mbili).
        <bold>
         c
        </bold>
        Jumla ya mabadiliko ya heteroplasmic ya mabadiliko ya de novo katika mayai baada ya mizunguko ya asili na OS, zilizovunjwa kwa kila eneo.
        <italic>
         n
        </italic>
        OS = 65 mayai,
        <italic>
         n
        </italic>
        Asili = 48 mayai. Mistari ya wima katika sehemu zinawakilisha wastani wa thamani katika grafu ya scatter, kila nukta inawakilisha sampuli.
        <bold>
         d
        </bold>
        Jumla ya idadi ya mabadiliko ya de novo katika jozi za mama na mtoto na katika mayai, iliyopangwa kulingana na umri wa mama wakati wa kuzaliwa au kukusanya mayai. Mfano wa Poisson wa regression ya generalized (PGLMR) unaonyesha kwamba uzee wa mama unahusiana kwa kiwango cha juu na jumla ya idadi ya mabadiliko ya de novo katika kizazi kinachofuata (
        <italic>
         p
        </italic>
        &lt; 0.001).
        <bold>
         e
        </bold>
        Idadi ya mabadiliko ya de novo ya non-synonymous na rRNA katika mayai, iliyopangwa kulingana na umri wa mama wakati wa kukusanya mayai. PGLMR inaonyesha kwamba uzee wa mama hauhusiani kwa kiwango cha juu na idadi ya mabadiliko ya de novo ya non-synonymous na rRNA katika mayai (
        <italic>
         p
        </italic>
        = 0.07).
        <bold>
         f
        </bold>
        Idadi ya mabadiliko ya de novo ya non-synonymous na rRNA katika mayai, iliyopangwa kulingana na idadi ya mayai yaliyokusanywa katika mzunguko. PGLMR inaonyesha kwamba ukubwa wa kikundi cha mayai kinahusiana kwa kiwango cha juu na idadi ya mabadiliko ya de novo ya non-synonymous na rRNA katika mayai (
        <italic>
         p
        </italic>
        = 0.007). BS: swab ya buccal, B: damu, U: tishu za njia ya mkojo, Katika (
        <bold>
         d
        </bold>
        –
        <bold>
         f
        </bold>
        ), ukubwa wa nukta ni sawia na idadi ya sampuli zilizo na hatua sawa ya data. Data ya chanzo zinatolewa kama faili ya data ya chanzo.
       </p>
      </caption>
      <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-45446-1/41467_2024_45446_Fig5_HTML.png" mime-subtype="PNG" specific-use="web"/>
     </fig>
    </p>
    <p id="Par19">
     Kwa jumla, tuligundua vigezo 113 vipya, vinavyosambazwa kwa usawa kati ya mayai ya mzunguko wa asili na mayai ya OS (maana ya 1.7 na 1.8 vigezo kwa kila yai kwa mayai ya asili na mayai ya OS, mtawalia, Fig.
     <xref ref-type="fig" rid="Fig5">
      5b
     </xref>
     , Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM8">
      5
     </xref>
     ). Pia hakukuwa na tofauti katika eneo la vigezo hivi vipya, na usambazaji sawa kati ya mayai ya asili na mayai ya OS katika maeneo yasiyo ya kuandika na katika maeneo ya rRNA, tRNA na vigeu vya kuandika protein (Fig.
     <xref ref-type="fig" rid="Fig5">
      5b
     </xref>
     ). Kwa mfano wa uchambuzi uliopita, tulipunguza utata wa data kwa kutoa jumla ya mizigo ya vigezo vipya katika kila yai (Fig.
     <xref ref-type="fig" rid="Fig5">
      5c
     </xref>
     ). Hatukugundua tofauti za kimakusudi katika mizigo ya vigezo kati ya mayai ya mizunguko ya asili na mayai ya OS.
    </p>
    <p id="Par20">
     Hatimaye, tulitumia regression kwa kutumia Muundo wa Mstari wa Poisson ili kujaribu kama idadi ya vigezo vipya katika jozi za mama na mtoto na katika mayai vilivyohusiana na mambo mengine, kama vile umri wa mama wakati wa kubadilishana, vitengo vya FSH vilivyotumika wakati wa OS na ukubwa wa kikundi cha mayai yaliyotolewa. Kwa mayai, tulitumia idadi ya wastani ya vigezo vipya kwa kila yai kwa kila mzungumzaji. Vitengo vya FSH havikuhusiana na vigezo vipya katika mifano yoyote tuliyopima, na viliondolewa kutoka kwa uchanganuzi. Katika kikundi kinachojumuisha mayai na jozi za mama na mtoto (
     <italic>
      N
     </italic>
     = 170), tuligundua kuwa kuzeeka kwa mama kuliongeza jumla ya idadi ya vigezo vipya (Fig.
     <xref ref-type="fig" rid="Fig5">
      5d
     </xref>
     na Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     ) na vigezo vya rRNA (Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     ) lakini si vigezo vya maana au visivyo vya maana (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      27
     </xref>
     ). Mifano iliyopimwa kwenye mayai (
     <italic>
      N
     </italic>
     = 113) ilionyesha kwamba umri wa mama na idadi ya mayai yaliyotolewa baada ya OS vilihusiana chanya na jumla ya idadi ya vigezo vipya vya mtDNA katika yai (Fig.
     <xref ref-type="fig" rid="Fig5">
      5
     </xref>
     e,
     <xref ref-type="fig" rid="Fig5">
      f
     </xref>
     , Jedwali
     <xref ref-type="table" rid="Tab5">
      5
     </xref>
     na Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      27
     </xref>
     ). Wakati umri wa mama ulihusiana kwa nguvu zaidi na jumla ya idadi ya vigezo vipya vya mtDNA na vigezo vya rRNA, idadi ya mayai yaliyotolewa ilihusiana chanya na idadi ya vigezo vipya visivyo vya maana na vigezo vya rRNA katika yai, ikipendekeza mbinu mbili tofauti za utekelezaji. Kwa kweli, umri wa mama ulikuwa mkubwa zaidi katika kundi la ART (Jedwali
     <xref ref-type="table" rid="Tab1">
      1
     </xref>
     ). Kwa hivyo, muungano wa kufanya OS na kuwa na umri wa mama mkubwa unaweza kueleza kwa nini watoto wa ART wana uwezekano mkubwa wa kubeba vigezo vipya visivyo vya maana na vigezo vya rRNA kuliko marafiki zao wa SC.
     <table-wrap id="Tab5">
      <label>
       Table 5
      </label>
      <caption xml:lang="en">
       <p>
        Mfano wa mstari uliopanuliwa na usambazaji wa Poisson kwa vigeu vya de novo katika jozi za mama na mtoto na mayai
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           (B)
          </p>
         </th>
         <th>
          <p>
           95% Wald C.I.
          </p>
         </th>
         <th>
          <p>
           Umuhimu
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="4">
          <p>
           <bold>
            Jumla ya idadi ya vigeu vya de novo
           </bold>
           <bold>
            katika jozi za mama na mtoto na mayai (
           </bold>
           <bold>
            <italic>
             N
            </italic>
           </bold>
           =
           <bold>
            170)
           </bold>
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           Umri wa mama
          </p>
         </td>
         <td>
          <p>
           0.037
          </p>
         </td>
         <td>
          <p>
           0.024–0.050
          </p>
         </td>
         <td>
          <p/>
         </td>
        </tr>
       </tbody>
      </table>
     </table-wrap>
    </p>
   </sec>
  </sec>
  <sec id="Sec7" sec-type="discussion">
   <title>
    Jadiliano
   </title>
   <p id="Par21">
    Soma hili linatambua, kwa mara ya kwanza, tofauti za kijeni kati ya watoto wa ART na SC ambazo zinahusiana na uzito wao wa kuzaliwa. Tuligundua kuwa mtDNA ya watoto wa ART mara nyingi huwasilisha vigezo katika maeneo ya kuandika protein na rRNA, na kwamba mara nyingi huchukua vigezo vipya visivyo vya maana kuliko marafiki zao wa SC. Kwa kutumia mifano ya regression na uchanganuzi wa kubainisha, tuligundua kuwa vigezo hivi visivyo vya maana na vigezo vya rRNA vinahusiana na uwezekano mkubwa wa kuzaliwa chini ya percentile ya 25 ya uzito wa kuzaliwa katika vikundi vyote viwili vya ART na SC, lakini na uhusiano mkubwa zaidi katika hilo la mwisho. Katika watoto wa ART, mazingira ya utamaduni yaliyowakabili wakati wa utamaduni wa kimatibabu wa yai kabla ya kubadilishwa yaligunduliwa kuwa sababu muhimu ya kuingilia kati, hasa katika mazingira ya utamaduni yaliyokolea sasa. Hatimaye, tuligundua kuwa kuzeeka kwa mama na, kwa watu wa ART, ukubwa wa kikundi cha mayai yaliyotolewa wakati wa OS, walikuwa mambo ya msingi yanayohusiana na uwezekano wa vigezo vipya katika watoto na mayai.
   </p>
   <p id="Par22">
    The exact mechanisms for the association between mtDNA variants and birthweight are to be elucidated, but the impact of mtDNA variation on health and disease is well-documented
    <sup>
     <xref ref-type="bibr" rid="CR62">
      62
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
     ,
     <xref ref-type="bibr" rid="CR75">
      75
     </xref>
    </sup>
    . Inherited disease-causing mtDNA variants are linked to low birthweight, obesity and insulin resistance, and mitochondrial haplogroups have been associated with a lower bioenergetic fitness, subfertility and obesity
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
     ,
     <xref ref-type="bibr" rid="CR41">
      41
     </xref>
     ,
     <xref ref-type="bibr" rid="CR42">
      42
     </xref>
     <xref ref-type="bibr" rid="CR76">
      76
     </xref>
     <xref ref-type="bibr" rid="CR77">
      77
     </xref>
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
    </sup>
    . A number of homoplasmic and heteroplasmic variants have been reported to be associated with body composition, although we were not able to replicate this finding in our study
    <sup>
     <xref ref-type="bibr" rid="CR43">
      43
     </xref>
     ,
     <xref ref-type="bibr" rid="CR44">
      44
     </xref>
     ,
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR46">
      46
     </xref>
     ,
     <xref ref-type="bibr" rid="CR47">
      47
     </xref>
     ,
     <xref ref-type="bibr" rid="CR48">
      48
     </xref>
     ,
     <xref ref-type="bibr" rid="CR49">
      49
     </xref>
    </sup>
    . Conversely, the obesity-associated haplogroup T, was under-represented in the lower birthweight individuals, and although the statistical significance was lost after correcting for multiple testing, these results are supporting the role of haplogroup T in modulating body weight. In our study, we find an association of birthweight with the presence of non-synonymous and rRNA heteroplasmic variants with a relatively low load and of unknown pathogenic potential, as they have not been associated with disease. Healthy individuals are known to carry heteroplasmic variants, most of which are not considered to be disease-causing
    <sup>
     <xref ref-type="bibr" rid="CR45">
      45
     </xref>
     ,
     <xref ref-type="bibr" rid="CR50">
      50
     </xref>
     <xref ref-type="bibr" rid="CR78">
      78
     </xref>
    </sup>
    . Nevertheless, these heteroplasmic variants can be a source of differences in health status and progression of ageing
    <sup>
     <xref ref-type="bibr" rid="CR75">
      75
     </xref>
    </sup>
    . For instance, variants inducing an amino-acid change or alterations in the transcription machinery can decrease the efficiency of the oxidative phosphorylation and increase the production of reactive oxygen species
    <sup>
     <xref ref-type="bibr" rid="CR79">
      79
     </xref>
    </sup>
    . Heteroplasmic variants are well-documented to play a key role in ageing, neurodegenerative diseases and cancer, and combinations of different non-pathogenic variants at low heteroplasmic loads, such as found in this study, have been proven to have a synergistic negative effect on mitochondrial function
    <sup>
     <xref ref-type="bibr" rid="CR80">
      80
     </xref>
     ,
     <xref ref-type="bibr" rid="CR81">
      81
     </xref>
     ,
     <xref ref-type="bibr" rid="CR82">
      82
     </xref>
     <xref ref-type="bibr" rid="CR83">
      83
     </xref>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    .
   </p>
   <p id="Par23">
    Uchunguzi wa kundi la wanafunzi na wazazi wao ulionyesha kuwa tofauti kati ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu (ART) na wale waliozaliwa kwa asili (SC) zilikuwa zikiongozwa na kuongezeka kwa mabadiliko ya vinasaba vya protein-coding na rRNA, pamoja na mabadiliko zaidi ya de novo non-synonymous protein-coding katika watu waliozaliwa baada ya ART. Tulidhania kuwa utunzaji wa OS unaweza kuwa sababu ya kuongezeka kwa mabadiliko haya ya de novo, lakini katika hatua ya kwanza hatukupata tofauti wakati wa kulinganisha moja kwa moja vigezo vya mtDNA katika mayai ya asili na mayai baada ya OS. Kinyume chake, tuligundua kuwa kuzeeka kwa umri wa mama kuna uhusiano chanya na idadi ya mabadiliko ya de novo yanayopatikana katika kizazi kinachofuata na ukubwa wa kundi la mayai yanayotolewa baada ya OS una uhusiano chanya na idadi ya mabadiliko ya non-synonymous na rRNA katika yai. Uhusiano tunaoipata kati ya umri wa mama na idadi ya mabadiliko ya de novo ya mtDNA katika watoto na mayai ni kamili katika mstari na utafiti mwingine uliofanywa kwenye jozi za mama na mtoto na kwenye mayai ya panya na makaku, ambapo uhusiano ulioeleweka kati ya umri wa mama na mtDNA mutational load imeamua. Kwa kuzingatia athari kubwa ya umri wa mama kwenye uzito wa kuzaliwa ambao tumegundua, inaonekana kuwa ni kweli kwamba kuongezeka kwa mabadiliko ya de novo ya mtDNA katika mayai yanaweza kuwa ni moja ya njia ambazo umri wa mama ulioendelea husababisha watoto waliozaliwa na uzito mdogo
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
     ,
     <xref ref-type="bibr" rid="CR86">
      86
     </xref>
     <xref ref-type="bibr" rid="CR87">
      87
     </xref>
     ,
     <xref ref-type="bibr" rid="CR88">
      88
     </xref>
     <xref ref-type="bibr" rid="CR89">
      89
     </xref>
     ,
     <xref ref-type="bibr" rid="CR90">
      90
     </xref>
     ,
     <xref ref-type="bibr" rid="CR91">
      91
     </xref>
    </sup>
    .
   </p>
   <p id="Par24">
    Katika watoto waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu, pamoja na kuzeeka kwa umri wa mama, ukubwa wa kundi la mayai una uhusiano na kuongezeka kwa mabadiliko ya non-synonymous na rRNA, uhusiano ambao, kwa ujuzi wetu, haumetajwa hapo awali. Maelezo yanayowezekana kwa utafiti huu ni kwamba utaratibu wa OS unafuta shindano kwa FSH kati ya changamano tofauti za follicle-oocyte zinazoanzisha utungaji katika mzunguko wa hedhi. Ukosefu huu wa shindano unaweza kuruhusu ovulation ya mayai yanayobeba mabadiliko ya mtDNA duni, kama vile mabadiliko ya non-synonymous na katika maeneo ya rRNA, ambayo kwa kawaida huwa hayana uwezo wa kushindana na yai kubwa zaidi katika mzunguko wa asili wa hedhi
    <sup>
     <xref ref-type="bibr" rid="CR86">
      86
     </xref>
     ,
     <xref ref-type="bibr" rid="CR92">
      92
     </xref>
     ,
     <xref ref-type="bibr" rid="CR93">
      93
     </xref>
    </sup>
    . Baadhi ya utafiti umechunguza uhusiano kati ya OS na uzito wa kuzaliwa, na matokeo yanayokinzana. Uzazi wa asili wa ART, bila OS, umegundua kuwa una uhusiano na uzito wa juu zaidi wa kuzaliwa kuliko mizunguko na OS kwa Mak et al., lakini si na Sunkara et al.
    <sup>
     <xref ref-type="bibr" rid="CR94">
      94
     </xref>
     <xref ref-type="bibr" rid="CR95">
      95
     </xref>
    </sup>
    . Vile vile, idadi ya mayai iliyotolewa imegundua kuwa ina uhusiano na uzito wa chini wa kuzaliwa katika baadhi ya makundi lakini si katika zingine
    <sup>
     <xref ref-type="bibr" rid="CR96">
      96
     </xref>
     <xref ref-type="bibr" rid="CR97">
      97
     </xref>
    </sup>
    . Sababu za utofauti huu bado hazijaelezwa na zinaweza kuwa, angalau kwa sehemu, kwa sababu ya athari kubwa ya vyombo vya utamaduni kwenye maendeleo ya embryonic na uzito wa kuzaliwa
    <sup>
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     ,
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
     ,
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
     ,
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
     ,
     <xref ref-type="bibr" rid="CR34">
      34
     </xref>
     ,
     <xref ref-type="bibr" rid="CR70">
      70
     </xref>
     ,
     <xref ref-type="bibr" rid="CR98">
      98
     </xref>
    </sup>
    .
   </p>
   <p id="Par25">
    Hatimaye, ni muhimu kuzingatia vikwazo vya utafiti huu. Kwanza, tunaripoti kuhusu makundi mawili ya sampuli, zilizoajiriwa katika vituo viwili tofauti, ambazo, wakati wa kuchambuliwa kando, hazifiki umuhimu wa takwimu kwa matokeo tunayoyaripoti. Pili, katika kundi hili la utafiti, hakuna tofauti katika uzito wa kuzaliwa kati ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa asili. Ni kweli kwamba tofauti katika aina za vinasaba vya mtDNA kati ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa asili (Fig.
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    ) zingekuwa zaidi za kina kama uzito wa kuzaliwa katika vikundi hivi viwili ungekuwa tofauti kwa wingi. Sababu inayoweza kuathiri hili ni kwamba watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu walikuwa wametumia vyombo tofauti vitatu vya utamaduni, ambavyo kwa wazi vina athari tofauti kwenye uzito wa kuzaliwa. Tatu, uhusiano tunaoipata kati ya vikundi vya vinasaba na uzito wa kuzaliwa huenda zisiwe na nguvu na zinapaswa kuchukuliwa kwa tahadhari, kwani hazishikilizi umuhimu wa takwimu katika mifano yote tuliyoijaribu. Zaidi ya hayo, wakati mifano ya kutofautisha uzito wa kuzaliwa wa asilimia 10 ni thabiti, mifano ya uzito wa kuzaliwa wa asilimia 25 ni tu kidogo tu na kinahitaji marekebisho na uboreshaji zaidi. Nne, mabadiliko tunayoyaripoti kuwa na uhusiano na uzito wa kuzaliwa hayana athari ya kibayolojia iliyothibitishwa zaidi ya ile ambayo inaweza kutoa na mifano ya kwenye kompyuta, na utafiti zaidi utahitajika ili kuonyesha kiungo cha kimatibabu. Hatimaye, ni muhimu kuzingatia kwamba wakati wa kuchambua tishu moja kwa kila mtu, haiwezi kuepukwa kwamba mabadiliko ya heteroplasmic yaliyopatikana ni ya kipekee kwa tishu, ambapo zingekuwa na uwezo mdogo wa kuathiri uzito wa kuzaliwa wa mtu. Kwa pamoja, utafiti wa ujumuishaji kwenye makundi makubwa zaidi utakuwa muhimu kwa kuthibitisha matokeo yetu na kuruhusu uboreshaji wa mifano ya kutabiri uzito wa kuzaliwa.
   </p>
   <p id="Par26">
    Kwa jumla, utafiti wetu umegundua uhusiano kati ya kuwepo kwa mabadiliko ya non-synonymous ya mtDNA heteroplasmic katika maeneo ya protein-coding na rRNA na uzito wa chini wa kuzaliwa, ambayo ni ya kawaida zaidi kwa watoto kutoka kwa wazazi wakubwa na waliouzaliwa baada ya matibabu ya uzazi uliofungamana na usaidizi wa kimatibabu. Tunapendekeza kuwa mabadiliko haya yanaweza kusababisha kushindwa kidogo cha kimatibabu cha mitochondrial lakini bado kinatosha kusababisha uzito wa chini wa kuzaliwa, na kutoa ushahidi wa kwanza kwa mambo ya kijeni ya mitochondrial ambayo yanaweza kueleza tofauti zinazoonekana kati ya watu waliozaliwa baada ya uzazi uliofungamana na usaidizi wa kimatibabu na wale waliozaliwa kwa asili. Matokeo ya muda mrefu ya afya ya mabadiliko haya bado hayajachunguzwa ili kubaini jinsi matokeo haya yataathiri mazoezi ya kimatibabu na ushauri wa wagonjwa katika siku zijazo.
   </p>
  </sec>
  <sec id="Sec8" sec-type="methods">
   <title>
    Mbinu
   </title>
   <p id="Par27">
    Kwa sehemu zote za utafiti huu, muundo na utekelezaji ulikidhi kanuni zote zinazofaa kuhusu matumizi ya washiriki wa utafiti wa binadamu, na vyote vilidhihirishwa na kamati ya maadili ya UZ Brussel na bodi ya ukaguzi wa maadili ya Maastricht University Medical Centre. Watu wote walitoa kibali chao kilichohifadhiwa na kilichoitwa kwa kuandikwa. Washiriki walikubali uchapishaji wa viambajengo vya kimatibabu katika aina ya kutotambulika. Utafiti huu ulifanywa kwa mujibu wa kanuni zilizowekwa na Azimio la Helsinki.
   </p>
   <sec id="Sec9">
    <title>
     Ujumuishaji na nyenzo za wadonyi
    </title>
    <p id="Par28">
     Washiriki waliochaguliwa katika Universitair Ziekenhuis Brussel (UZ Brussel, Ubelgiji) na katika Maastricht University Medical Centre (MUMC, Uholanzi). Washiriki wote walitoa kibali cha ufahamu na hawakupokea malipo isipokuwa ilivyoelezwa tofauti. Watoto wote wa ART walizaliwa kutokana na ubadilishanaji wa embrio huria katika hatua ya mgawanyiko, maelezo kuhusu matumizi ya utupu wa sperimu ndani ya seli (ICSI) au kuzaliana kwa ndani ya vitamaduni ni dhahiri kwa ajili ya mizunguko 150 tu ya 270 ya ART. Taarifa hii haikutumika katika uchambuzi kwa sababu ICSI imepatikana kuwa haiongezei hatari ya matokeo mabaya ya kabla ya kuzaliwa
     <sup>
      <xref ref-type="bibr" rid="CR99">
       99
      </xref>
     </sup>
     . Nakala za DNA zilizoondolewa kutoka kwa damu ya watoto wachanga zilikuwa nyenzo za ziada zilizochaguliwa katika UZ Brussel kwa ajili ya utafiti uliolenga kujua kama DNA ya mitochondrial ya baba inaweza kupatikana kwa watu waliozaliwa baada ya ICSI
     <sup>
      <xref ref-type="bibr" rid="CR100">
       100
      </xref>
     </sup>
     . Wazazi walitoa kibali cha ufahamu. Tume ya kimaadili ilitoa ruhusa ya kutumia nakala za DNA zilizohifadhiwa kwa ajili ya utafiti huu, lakini si vipimo vya kimatibabu vinavyohusiana. Nakala za DNA za watoto waliokomaa miaka 9 zilichaguliwa katika MUMC, kama sehemu ya utafiti wa kufuatilia kwa muda mrefu kuhusu utafiti wa uchunguzi wa uangalizi
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     . Wazazi walitafutwa baada ya siku za kuzaliwa za mtoto wao ili kushiriki katika utafiti huu. Kamati ya maadili ya ndani iliidhinisha utafiti huu na wazazi wote wa watoto walitoa kibali cha ufahamu kilichohaririwa. DNA iliondolewa kutoka kwa nakala za mkojo. Nakala za DNA za placenta zilichukuliwa kwa ajili ya utafiti ulioandaliwa na MUMC
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
      ,
      <xref ref-type="bibr" rid="CR70">
       70
      </xref>
     </sup>
     . Idhini ya kimaadili ilihitajika lakini ilikataliwa, kwa mujibu wa sheria za Uholanzi, tishu za ziada za placenta zinaweza kutumika kwa ajili ya utafiti baada ya kibali cha mgonjwa, bila ruhusa zaidi ya kamati ya maadili kwa kuwa hakukuwa na uingiliaji wowote unaohitajika ili kupata sampuli. Sampuli za biopsi za placenta zilichukuliwa katika vituo 6 vya IVF nchini Uholanzi (Amsterdam UMC, sehemu ya AMC huko Amsterdam, Hospitali ya Catharina huko Eindhoven, Hospitali ya St. Elisabeth huko Tilburg, Kituo cha Matibabu cha Chuo Kikuu cha Maastricht huko Maastricht na Kituo cha Matibabu cha Chuo Kikuu cha Groningen huko Groningen) na vituo 5 vya IVF vinavyohusiana na hospitali hizi, wagonjwa wote walitoa kibali cha ufahamu
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     . Maelezo kuhusu ukusanyaji na uondoaji wa sampuli yanaweza kupatikana katika kazi iliyochapishwa awali
     <sup>
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
      ,
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     . Watoto waliokomaa miaka 18 wa ART, sampuli zilichukuliwa kama sehemu ya mradi mkubwa zaidi kuhusu afya ya moyo na mishipa na uzazi wa wanawake na wanaume waliokomaa waliozaliwa baada ya ICSI iliyofanyika katika UZ Brussel
     <sup>
      <xref ref-type="bibr" rid="CR101">
       101
      </xref>
      ,
      <xref ref-type="bibr" rid="CR102">
       102
      </xref>
     </sup>
     . Watu hawa ni sehemu ya kikundi ambacho kimekuwa chini ya uangalizi wa muda mrefu tangu kuzaliwa. Wazazi wote wa watoto waliofaa wa ICSI katika data yetu walipokea barua inayoeleza muktadha na mpango wa utafiti. Baada ya hapo, wazazi hawa walifonwa ili kujua nia yao na ya watoto wao kushiriki. Baada ya kibali cha wazazi kupatikana, vijana hawa walitafutwa moja moja na kuulizwa kushiriki. Washiriki wote walitoa kibali cha ufahamu na walipokea motisha kwa njia ya voucher ya zawadi. DNA iliondolewa kutoka kwa damu ya periferal. Kamati ya maadili ya ndani ya UZ Brussel iliidhinisha utafiti huu. Watoto waliokomaa miaka 18 wa SC walichaguliwa kama wanafunzi wa mwaka wa kwanza katika kambi ya Chuo Kikuu cha Vrije Universiteit Brussel. Walitafutwa kwenye kambi, ambapo walipokea brosha ya habari kuhusu utafiti, fomu ya kibali cha ufahamu na nyenzo zinazohitajika ili kutoa swab ya mdomo. Volunta waliojiandikisha kwenye utafiti huu walitoa kibali cha ufahamu kabla ya kutoa sampuli. Utafiti huu uliidhinishwa na kamati ya maadili ya ndani ya UZ Brussel.
    </p>
    <p id="Par29">
     Kwa ajili ya utafiti wa oocytes, wanawake 29 waliwapa oocytes zao katika mizunguko ya asili ya hedhi na baada ya mzunguko mmoja wa OS. Wadonaji wote walichaguliwa katika Kituo cha Matibabu ya Uzazi wa UZ Brussel, kama sehemu ya programu ya kawaida ya kutoa oocytes, ambapo pia matibabu yote yalifanyika. Wadonaji wote walitoa kibali cha ufahamu kwa ajili ya matibabu yote na kwa ajili ya kutumia oocytes zao kwa utafiti, na walipokea malipo ya kifedha. Kamati ya maadili ya ndani ya UZ Brussel iliidhinisha sehemu zote za utafiti huu. Vigezo vya kuchaguliwa vilikuwa: umri wa miaka 19-35, afya njema na na uzito wa mwili kati ya 18-32. Vigezo vya kutochaguliwa vilikuwa: hali yoyote ya kimatibabu au ya kijeni inayoweza kuingilia afya ya oocytes, daraja la endometriosis la American Fertility Society (AFS) III-IV, matatizo ya kunyonya yaliyohusiana na mashirika ya 1-6 ya Shirika la Afya Ulimwenguni (WHO), uzito wa mwili chini ya 18 au zaidi ya 32, matumizi ya dawa inayoweza kuingilia uwezo wa oocytes na matatizo ya akili. Wadonaji walipitia aina mbili za mizunguko ya kutoa oocytes: hadi mizunguko mitatu ya asili na mzunguko mmoja baada ya OS (Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      25
     </xref>
     ). Katika kipindi cha kutoa oocytes cha mzunguko wa asili, sampuli ya damu ilichukuliwa siku ya 2 ya mzunguko wa follicular ili kuchunguza mambo mbalimbali: estradiol ya serum, progesterone, homoni ya luteinizing, homoni ya kukuza follicles (FSH), na viwango vya human chorionic gonadotrophin (hCG). Siku ya 10, sampuli ya damu ilichukuliwa tena ili kuthibitisha mambo hayo hayo isipokuwa hCG pamoja na ultrasound ya vaginal ili kuchunguza maendeleo ya follicular. Ikiwa haikutosha, sampuli za ziada za damu na ultrasound zilichukuliwa. Uchukuzi wa oocytes ulifanyika 32 masaa baada ya kutoa 5000 IU ya hCG ya nje. Mzunguko wa OS ulianza siku ya kwanza ya hedhi inayofuata mzunguko wa asili. Kuanzia siku ya 2 ya mzunguko, protokoli ya antagonist ya homoni ya kukuza gonadotrophin (GnRH) ilitumika, kwa kutumia FSH ya kijeni ikiwa uchanganuzi wa homoni ulikuwa ndani ya mipaka ya kawaida siku ya 2. Dawa ya kuanzia ya FSH ilibadilika kati ya 150-300 IU kwa siku. Siku ya 6 ya kuchochea, antagonist ya GnRH (Ganirelix; Orgalutran®; MSD, Oss, Uholanzi) na dawa ya 0.25 mg kwa siku ilitoa. Kumaliza ukuaji wa oocytes ulifanyika kwa kutoa GnRH agonist (Gonapeptyol®, Ferring Pharmaceuticals, St-Prex, Uswisi) na dawa ya 0.2 ml wakati follicles 3 zilifikia kipenyo cha wastani cha 17-20 mm. Uchukuzi wa oocytes ulifanyika kwa mujibu wa utaratibu wa kawaida, 36 masaa baada ya kichocheo.
    </p>
   </sec>
   <sec id="Sec10">
    <title>
     Utengenezaji wa DNA na utaratibu wa PCR wa muda mrefu kwa ajili ya kuongeza mtDNA
    </title>
    <p id="Par30">
     DNA iliondolewa kutoka kwa damu ya periferal, placenta, mkojo na swab ya mdomo, na kutoka kwa oocytes za kibinafsi kama ilivyoelezwa awali na kikundi chetu
     <sup>
      <xref ref-type="bibr" rid="CR103">
       103
      </xref>
      ,
      <xref ref-type="bibr" rid="CR104">
       104
      </xref>
     </sup>
     . DNA ya mitochondrial iliboreshwa kwa PCR ya muda mrefu kwa kutumia seti mbili za primers ili kufunika mtDNA kamili katika sampuli za DNA za jumla. Kwa oocytes za kibinafsi, seti ya kwanza ya primers pekee iliyotumika. Mifuatano ya seti ya kwanza ya primers (5042f-1424r) ilikuwa 5′-AGC AGT TCT ACC GTA CAA CC-3′ (mbele) na 5′-ATC CAC CTT CGA CCC TTA AG-3′ (nyuma) ikitoa amplicons ya 12.9 Kb. Mifuatano ya seti ya pili ya primers (528f-5789r) ilikuwa 5′-TGC TAA CCC CAT ACC CCG AAC C-3′ (mbele) na 5′-AAG AAG CAG CTT CAA ACC TGC C-3′ (nyuma) ikitoa amplicons ya 5.3 Kb. Seti zote mbili za primers zilininunuliwa kutoka kwa Integrated DNA Technologies, zilidilutiwa hadi 10 µmol na kuhifadhiwa kwa -20 °C. Mchanganyiko wa kuanza kwa PCR ya muda mrefu ulipangwa kama ifuatavyo: 10 µL ya 5x LongAmp buffer (LongAmp Taq DNA Polymerase kit M0323L, New England Biolabs, iliyohifadhiwa kwa -20 °C), 7.5 µL dNTPs (dNTP set, IllustraTM, iliyodilutiwa hadi 2 mM na kuhifadhiwa kwa -20 °C), 2 µL ya primers za mbele na nyuma (10 µM), 2 µL ya Taq Polymerase LongAmp (5 units) na 50 ng ya DNA iliyodilutiwa (suluhisho la kazi: 10 ng/µL) katika jumla ya 50 µL. Katika kesi ya oocytes, PCR ya muda mrefu ya seli moja iliyotumika. Hapa, seti ya kwanza ya primers pekee iliyotumika na 2.5 µL ya Tricine (Sigma-Aldrich T9784, iliyodilutiwa hadi 200 nM na kuhifadhiwa kwa 4 °C) iliongezwa ili kubadilisha buffer ya usagaji wa kiwango cha juu (200 mM NaOH na 50 mM DTT) iliyotumika katika ukusanyaji wa oocytes. Mchanganyiko wa kuanza uliongezwa moja kwa moja kwenye sampuli. Uchanganuzi wa PCR ulithibitishwa kwa kufanya gel-electrophoresis. Uchambuzi wa seti za primers kwa ajili ya jeni ya mitochondrial ulidhibitiwa kwa kuchanganya DNA ya RhoZero cells, ambazo hazina DNA ya mitochondrial. Mbinu za kina zaidi za PCR ya muda mrefu na uthibitishaji wa mbinu hii zimechapishwa awali
     <sup>
      <xref ref-type="bibr" rid="CR104">
       104
      </xref>
      ,
      <xref ref-type="bibr" rid="CR105">
       105
      </xref>
     </sup>
     .
    </p>
   </sec>
   <sec id="Sec11">
    <title>
     Utayarishaji wa sampuli kwa ajili ya kuandika data na uchanganuzi wa data
    </title>
    <p id="Par31">
     Baada ya PCR, sampuli zilishughulikiwa kwa kutumia AMPure beads na amplicons kutoka kwa seti zote mbili za primers zilichanganywa pamoja katika uwiano wa 0.35/0.65 (35% ya amplicon kutoka kwa seti ya pili ya primers na 65% ya amplicon kutoka kwa seti ya kwanza ya primers). Kisha, maktaba iliyopangwa kwa kutumia KAPA HyperPlus kit na ilishughulikiwa kwa kutumia AMPure beads. Ubora wa maktaba ulithibitishwa kwa electrophoresis kwenye AATI Fragment Analyzer kwa kutumia HS NGS Fragment kit. Kisha, maktaba yalidilutiwa hadi 2 nM katika EBT buffer na kuchanganywa kabla ya kuchambua kwa kutumia jukwaa la Illumina. Data ya uchapishaji wa awali inachukuliwa kuwa data ya kibinafsi na sheria ya Ulaya (Regulation (EU) 2016/679) na haiwezi kushirikiwa hadharani. Data inaweza kupatikana kutoka kwa mwandishi mwenza kwa ombi la busara na baada ya kutoa Makubaliano ya Matumizi ya Data. Usanidi wa kufuatilia kwenye jeni ya kurejelea (NC_0.12920.1) ulifanywa kwa kutumia BWA-MEM. Faili za bam zilizotengenezwa ziliwekwa kwenye jukwaa la mtandao la “mtDNA server” ili kubainisha kundi la mtDNA na kutambua aina nyingine za homoplasmic na heteroplasmic
     <ext-link ext-link-type="uri" href="https://mitoverse.i-med.ac.at/">
      https://mitoverse.i-med.ac.at/
     </ext-link>
     ) na MuTect2 iliyotumika ili kugundua uingizwaji mdogo na uondoaji. Aina zilizo na kiwango cha juu zaidi ya 1.5% cha heteroplasmic (yaani, angalau 1.5% ya molekuli zilizochapishwa zilizo na aina) au angalau 2% katika kesi ya oocytes za kibinafsi, zilionekwa na mabadiliko ya asidi ya amino yanayowezekana yalibainishwa kwa kutumia MitImpact2
     <sup>
      <xref ref-type="bibr" rid="CR106">
       106
      </xref>
      <xref ref-type="bibr" rid="CR107">
       107
      </xref>
      <xref ref-type="bibr" rid="CR108">
       108
      </xref>
     </sup>
     . Homoplasmies zilifafanuliwa kuwa aina zenye kiwango cha juu zaidi ya 98.5% (100% minus kiwango cha ugunduzi) kwa ajili ya sampuli za watoto na wazazi, kwa ajili ya oocytes hii ilikuwa zaidi ya 98%. Tuliondoa aina zilizotambuliwa katika seti tofauti za maeneo ambayo yalikuwa na uwezekano wa kutoa makosa ya PCR na uchapishaji, na kusababisha 1037 bp kuondolewa kutoka kwa uchanganuzi wa mwisho (Fig.
     <xref ref-type="fig" rid="Fig1">
      1a
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      28
     </xref>
     ). Aina zilizotambuliwa katika sampuli zote zilizojumuishwa katika utafiti huu zimeorodheshwa katika faili ya data ya ziada, ikijumuisha alama za uwezekano wa madhara ya aina ambazo ni za kuandika upya protini au tRNA. Alama za uwezekano wa madhara zilitolewa kwa uchanganuzi wa kibinafsi kwa kutumia MutPred2 kwa aina zisizo za kuandika upya protini na MitoTip kwa aina za tRNA. Alama za MutPred2 zaidi ya 0.61 na alama za MitoTip zaidi ya 50% zilichukuliwa kuwa na uwezekano wa madhara. Mbinu hii, ikijumuisha PCR, uchapishaji na uchanganuzi wa data, ilikuwa imeratibiwa awali katika lab yetu na kuthibitishwa kwa kina na kiwango cha chini cha ugunduzi (kiwango cha heteroplasmic) cha 2% kwa ajili ya seli za kibinafsi na 1.5% kwa ajili ya nyenzo za jumla, kulingana na uchanganuzi wa mara kwa mara wa sampuli sawa, ikijumuisha seli nyingi za kibinafsi na mchanganyiko wa sampuli za DNA ili kufanana na viwango tofauti vya heteroplasmy
     <sup>
      <xref ref-type="bibr" rid="CR71">
       71
      </xref>
      <xref ref-type="bibr" rid="CR109">
       109
      </xref>
      <xref ref-type="bibr" rid="CR105">
       105
      </xref>
      ,
      <xref ref-type="bibr" rid="CR110">
       110
      </xref>
      ,
      <xref ref-type="bibr" rid="CR111">
       111
      </xref>
     </sup>
     . Aina zote za DNA za mitochondrial zilizotambuliwa katika sampuli zote zimepewa pamoja na karatasi hii katika faili ya Data ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM9">
      6
     </xref>
     .
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     Takwimu
    </title>
    <p id="Par32">
     Uchanganuzi wa takwimu ulifanywa kwa kutumia SPSS (IBM). Aina za heteroplasmic zilichambuliwa kwa kutumia uchanganuzi wa kuchunguza kwa kugeuza kwa njia ya orthogonal, ambayo inatoa mabadiliko kati ya vigeu katika mfumo wa vigeu huru vya kudumu (maelezo zaidi yanaweza kupatikana katika faili ya maelezo ya ziada, katika Fig. ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     , Jedwali la Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      29
     </xref>
     na Fig. ya Ziada
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ). Uregreshaji wa kimantiki wa binary na uchanganuzi wa kubainisha ulitumika kuunda miundo ya kutabiri athari za vigeu tofauti kwenye asilimia ya uzito wa kuzaliwa. Kwa ajili ya haya, sampuli zenye data zisizo kamili ziliondolewa kutoka kwa uchanganuzi. Uchanganuzi wengine wa takwimu ulifanywa kwa kutumia Fisher’s exact, Mann–Whitney U na Student t-test. Jaribio zote za takwimu zilifanywa kwa pande zote mbili na thamani za
     <italic>
      p
     </italic>
     -zaidi ya 0.05 zilichukuliwa kuwa muhimu. Urekebishaji kwa ajili ya majaribio mengi ulifanywa kwa kutumia mbinu ya Bonferroni, na kiwango kilichorekebishwa cha umuhimu kinatolewa ambapo inafaa.
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     Ripoti fupi
    </title>
    <p id="Par33">
     Maelezo zaidi kuhusu muundo wa utafiti yanapatikana katika
     <xref ref-type="supplementary-material" rid="MOESM10">
      Ripoti ya Matokeo ya Muundo wa Utafiti wa Nature Portfolio
     </xref>
     iliyounganishwa na makala hii.
    </p>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    Shukrani
   </title>
   <p>
    Wananchi wanatamani kutoa shukrani za dhati kwa wafanyakazi wote wa Kituo cha Matibabu ya Uzazi katika UZ Brussel kwa ushiriki wao katika tafiti hii, na kushukuru Hatice Satilmis, Jo Bossuyt na Khadija Rhioui kwa usaidizi wao katika ukusanyaji wa data kwa ajili ya karatasi hii. Pia tunashukuru Iain Johnston na Joanna Poulton kwa kusoma kwa makini na michango muhimu ya kisayansi kwa kazi yetu. Utafiti huu ulifadhiliwa na Taasisi ya Utafiti Flanders (FWO, Nambari za Mafunzo 1506617N na 1506717N, kwa C.S.), na Taasisi ya Utafiti Willy Gepts ya UZ Brussel (Nambari za Mafunzo WFWG14-15, WFWG16-43, WFWG19-19, kwa C.S.), Mradi wa Methusalem wa Chuo Kikuu cha Vrije Universiteit Brussel (kwa K.S.), na March of Dimes (6-FY13-153 kwa A.P.A.V.M). M.R. na E.C.D.D. ni washiriki wa shahada ya kwanza wanaofadhiliwa na FWO, Nambari za Mafunzo 1133622N na 1S73521N, mtawalia.
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    Michango ya Waandishi
   </title>
   <p>
    J.M., F.B., A.P.A.V.M., M.B., K.St. na F.Z. walichangia katika kuajiri washiriki wa tafiti, kuandaa sampuli na kukusanya viambajengo vya kimatibabu. H.V.D.V., H.T. na C.B. walichangia katika kuajiri watoa ova na walikuwa wanaohusika na utaratibu wa kimatibabu wa kuvuta ova na ukusanyaji. J.M. na F.Z. walifanya maandalizi ya sampuli kwa ajili ya DNA sequencing. J.M. na E.C.D.D. walifanya uchanganuzi wa bioinformatic wa data ya sequencing. J.M. alikusanya na kuhifadhi seti ya data. M.R. alibuni figuras zote kwenye karatasi na akachangia katika uchanganuzi wa takwimu. K.B. alitoa ushauri kuhusu mbinu zote za takwimu na alibuni uchambuzi wa sababu kwa vigeu vya mitochondrial. S.S. na H.S. walichangia katika tafsiri ya vigeu vya mitochondrial na muundo wa jumla wa tafiti. K.Se. alitoa ufadhili kwa tafiti hii na akachangia katika muundo wa jumla wa tafiti. J.M. na C.S. walifanya uchanganuzi wa takwimu, walitafsiri matokeo na walishirikiana katika kuandika karatasi. C.S. alibuni tafiti, alitoa ufadhili na kusimamia tafiti. Waandishi wote waliosoma karatasi na kuiidhinisha katika muundo wake wa mwisho.
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    Uchunguzi wa kielimu
   </title>
   <sec id="FPar1">
    <title>
     Maelezo ya uchunguzi wa kielimu
    </title>
    <p id="Par34">
     <italic>
      Nature Communications
     </italic>
     thanks the anonymous reviewers for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    Upatikanaji wa data
   </title>
   <p>
    The raw sequencing data is considered personal data by the General Data Protection Regulation of the European Union (Regulation (EU) 2016/679) and cannot be publicly shared. The data can be obtained from the corresponding author upon request and after signing a Data Use Agreement. All mitochondrial DNA variants called in all samples are provided with this paper in the Supplementary Data
    <xref ref-type="supplementary-material" rid="MOESM9">
     6
    </xref>
    file, as well as the clinical parameters associated to the samples.
    <xref ref-type="sec" rid="Sec15">
     Source data
    </xref>
    are provided with this paper.
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     Mashindano ya masilahi
    </title>
    <p id="Par35">
     The authors declare no competing interests.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    Marudio
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luke
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The risk of birth defects with conception by ART
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2021
      </year>
      <volume>
       36
      </volume>
      <fpage>
       116
      </fpage>
      <lpage>
       129
      </lpage>
      <pub-id pub-id-type="pmid">
       33251542
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa272
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Qin
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis
      </article-title>
      <source>
       Arch. Gynecol. Obstet.
      </source>
      <year>
       2017
      </year>
      <volume>
       295
      </volume>
      <fpage>
       285
      </fpage>
      <lpage>
       301
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XitVWms7rF
      </pub-id>
      <pub-id pub-id-type="pmid">
       27896474
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00404-016-4250-3
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pandey
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Shetty
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Hamilton
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Maheshwari
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2012
      </year>
      <volume>
       18
      </volume>
      <fpage>
       485
      </fpage>
      <lpage>
       503
      </lpage>
      <pub-id pub-id-type="pmid">
       22611174
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dms018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pinborg
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2013
      </year>
      <volume>
       19
      </volume>
      <fpage>
       87
      </fpage>
      <lpage>
       104
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC3s7js1SktA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23154145
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dms044
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Maheshwari
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2018
      </year>
      <volume>
       24
      </volume>
      <fpage>
       35
      </fpage>
      <lpage>
       58
      </lpage>
      <pub-id pub-id-type="pmid">
       29155965
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmx031
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Magnusson
        </surname>
        <given-names>
         Å
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The association between high birth weight and long-term outcomes—implications for assisted reproductive technologies: a systematic review and meta-analysis
      </article-title>
      <source>
       Front. Pediatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       675775
      </fpage>
      <pub-id pub-id-type="pmid">
       34249812
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8260985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fped.2021.675775
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sargisian
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cancer in children born after frozen-thawed embryo transfer: a cohort study
      </article-title>
      <source>
       PLoS Med.
      </source>
      <year>
       2022
      </year>
      <volume>
       19
      </volume>
      <fpage>
       e1004078
      </fpage>
      <pub-id pub-id-type="pmid">
       36048761
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9436139
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pmed.1004078
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Are ICSI adolescents at risk for increased adiposity?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2012
      </year>
      <volume>
       27
      </volume>
      <fpage>
       257
      </fpage>
      <lpage>
       264
      </lpage>
      <pub-id pub-id-type="pmid">
       22081314
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/der375
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ceelen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Van Weissenbruch
        </surname>
        <given-names>
         MM
        </given-names>
       </name>
       <name>
        <surname>
         Vermeiden
        </surname>
        <given-names>
         JPW
        </given-names>
       </name>
       <name>
        <surname>
         Van Leeuwen
        </surname>
        <given-names>
         FE
        </given-names>
       </name>
       <name>
        <surname>
         Delemarre-Van De Waal
        </surname>
        <given-names>
         HA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Cardiometabolic differences in children born after in vitro fertilization: follow-up study
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2008
      </year>
      <volume>
       93
      </volume>
      <fpage>
       1682
      </fpage>
      <lpage>
       1688
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXlvFWgs78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       18285409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2007-2432
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ceelen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         van Weissenbruch
        </surname>
        <given-names>
         MM
        </given-names>
       </name>
       <name>
        <surname>
         Vermeiden
        </surname>
        <given-names>
         JPW
        </given-names>
       </name>
       <name>
        <surname>
         van Leeuwen
        </surname>
        <given-names>
         FE
        </given-names>
       </name>
       <name>
        <surname>
         Delemarre-van de Waal
        </surname>
        <given-names>
         HA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Pubertal development in children and adolescents born after IVF and spontaneous conception
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2008
      </year>
      <volume>
       23
      </volume>
      <fpage>
       2791
      </fpage>
      <lpage>
       2798
      </lpage>
      <pub-id pub-id-type="pmid">
       18689849
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/den309
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cui
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Increased risk of metabolic dysfunction in children conceived by assisted reproductive technology
      </article-title>
      <source>
       Diabetologia
      </source>
      <year>
       2020
      </year>
      <volume>
       63
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXhsFKltLzM
      </pub-id>
      <pub-id pub-id-type="pmid">
       32757153
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00125-020-05241-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guo
        </surname>
        <given-names>
         X-Y
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cardiovascular and metabolic profiles of offspring conceived by assisted reproductive technologies: a systematic review and meta-analysis
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2017
      </year>
      <volume>
       107
      </volume>
      <fpage>
       622
      </fpage>
      <lpage>
       631.e5
      </lpage>
      <pub-id pub-id-type="pmid">
       28104241
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2016.12.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Meister
        </surname>
        <given-names>
         TA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Association of assisted reproductive technologies with arterial hypertension during adolescence
      </article-title>
      <source>
       J. Am. Coll. Cardiol.
      </source>
      <year>
       2018
      </year>
      <volume>
       72
      </volume>
      <fpage>
       1267
      </fpage>
      <lpage>
       1274
      </lpage>
      <pub-id pub-id-type="pmid">
       30190005
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.jacc.2018.06.060
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valenzuela‐Alcaraz
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Postnatal persistence of fetal cardiovascular remodelling associated with assisted reproductive technologies: a cohort study
      </article-title>
      <source>
       BJOG Int. J. Obstet. Gynaecol.
      </source>
      <year>
       2019
      </year>
      <volume>
       126
      </volume>
      <fpage>
       291
      </fpage>
      <lpage>
       298
      </lpage>
      <pub-id pub-id-type="doi">
       10.1111/1471-0528.15246
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gluckman
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Hanson
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Phil
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <name>
        <surname>
         Cooper
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Thornburg
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Disease, effect of in utero and early-life conditions on adult health and disease
      </article-title>
      <source>
       N. Engl. J. Med.
      </source>
      <year>
       2014
      </year>
      <volume>
       359
      </volume>
      <fpage>
       61
      </fpage>
      <lpage>
       73
      </lpage>
      <pub-id pub-id-type="doi">
       10.1056/NEJMra0708473
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Middelburg
        </surname>
        <given-names>
         KJ
        </given-names>
       </name>
       <name>
        <surname>
         Haadsma
        </surname>
        <given-names>
         ML
        </given-names>
       </name>
       <name>
        <surname>
         Heineman
        </surname>
        <given-names>
         MJ
        </given-names>
       </name>
       <name>
        <surname>
         Bos
        </surname>
        <given-names>
         AF
        </given-names>
       </name>
       <name>
        <surname>
         Hadders-Algra
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ovarian hyperstimulation and the in vitro fertilization procedure do not influence early neuromotor development; a history of subfertility does
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2010
      </year>
      <volume>
       93
      </volume>
      <fpage>
       544
      </fpage>
      <lpage>
       553
      </lpage>
      <pub-id pub-id-type="pmid">
       19361794
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2009.03.008
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Romundstad
        </surname>
        <given-names>
         LB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2008
      </year>
      <volume>
       372
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id pub-id-type="pmid">
       18674812
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(08)61041-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         Antonisamy
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Redla
        </surname>
        <given-names>
         AC
        </given-names>
       </name>
       <name>
        <surname>
         Kamath
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Female causes of infertility are associated with higher risk of preterm birth and low birth weight: analysis of 117 401 singleton live births following IVF
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2021
      </year>
      <volume>
       36
      </volume>
      <fpage>
       676
      </fpage>
      <lpage>
       682
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXitValsb%2FK
      </pub-id>
      <pub-id pub-id-type="pmid">
       33367914
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa283
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cooper
        </surname>
        <given-names>
         AR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Smaller fetal size in singletons after infertility therapies: the influence of technology and the underlying infertility
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2011
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1100
      </fpage>
      <lpage>
       1106
      </lpage>
      <pub-id pub-id-type="pmid">
       21944928
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3212582
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2011.08.038
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luke
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Gopal
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <name>
        <surname>
         Cabral
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Diop
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Stern
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status
      </article-title>
      <source>
       J. Assist. Reprod. Genet.
      </source>
      <year>
       2016
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1203
      </fpage>
      <lpage>
       1213
      </lpage>
      <pub-id pub-id-type="pmid">
       27318927
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5010815
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10815-016-0757-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kalra
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         Ratcliffe
        </surname>
        <given-names>
         SJ
        </given-names>
       </name>
       <name>
        <surname>
         Coutifaris
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Molinaro
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Barnhart
        </surname>
        <given-names>
         KT
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ovarian stimulation and low birth weight in infants conceived through in vitro fertilization
      </article-title>
      <source>
       Obstet. Gynecol.
      </source>
      <year>
       2011
      </year>
      <volume>
       118
      </volume>
      <fpage>
       863
      </fpage>
      <pub-id pub-id-type="pmid">
       21934450
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3178887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/AOG.0b013e31822be65f
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kapiteijn
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does subfertility explain the risk of poor perinatal outcome after IVF and ovarian hyperstimulation?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2006
      </year>
      <volume>
       21
      </volume>
      <fpage>
       3228
      </fpage>
      <lpage>
       3234
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD28nnsFGgtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       17023490
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/del311
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Pelinck
        </surname>
        <given-names>
         MJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is the birthweight of singletons born after IVF reduced by ovarian stimulation or by IVF laboratory procedures?
      </article-title>
      <source>
       Reprod. Biomed. Online
      </source>
      <year>
       2010
      </year>
      <volume>
       21
      </volume>
      <fpage>
       245
      </fpage>
      <lpage>
       251
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC3cfgtVSmsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       20538525
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.rbmo.2010.04.024
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhu
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Chen
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <name>
        <surname>
         Liu
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Qiao
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The protein source in embryo culture media influences birthweight: a comparative study between G1 v5 and G1-PLUS v5
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       1387
      </fpage>
      <lpage>
       1392
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhtVaks7nP
      </pub-id>
      <pub-id pub-id-type="pmid">
       24812314
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu103
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Dumoulin
        </surname>
        <given-names>
         JC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of in vitro culture of human embryos on birthweight of newborns
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2010
      </year>
      <volume>
       25
      </volume>
      <fpage>
       605
      </fpage>
      <lpage>
       612
      </lpage>
      <pub-id pub-id-type="pmid">
       20085915
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dep456
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kleijkers
        </surname>
        <given-names>
         SHM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Influence of embryo culture medium (G5 and HTF) on pregnancy and perinatal outcome after IVF: a multicenter RCT
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2219
      </fpage>
      <lpage>
       2230
      </lpage>
      <pub-id pub-id-type="pmid">
       27554441
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew156
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunde
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Time to take human embryo culture seriously
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2174
      </fpage>
      <lpage>
       2182
      </lpage>
      <pub-id pub-id-type="pmid">
       27554442
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew157
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zandstra
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Van Montfoort
        </surname>
        <given-names>
         APA
        </given-names>
       </name>
       <name>
        <surname>
         Dumoulin
        </surname>
        <given-names>
         JCM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Does the type of culture medium used influence birthweight of children born after IVF?
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2015
      </year>
      <volume>
       30
      </volume>
      <fpage>
       530
      </fpage>
      <lpage>
       542
      </lpage>
      <pub-id pub-id-type="pmid">
       25574031
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu346
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mani
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Ghosh
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Coutifaris
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Sapienza
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Mainigi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic changes and assisted reproductive technologies
      </article-title>
      <source>
       Epigenetics
      </source>
      <year>
       2020
      </year>
      <volume>
       15
      </volume>
      <fpage>
       12
      </fpage>
      <lpage>
       25
      </lpage>
      <pub-id pub-id-type="pmid">
       31328632
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1080/15592294.2019.1646572
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         El Hajj
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Haaf
        </surname>
        <given-names>
         T
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic disturbances in in vitro cultured gametes and embryos: implications for human assisted reproduction
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2013
      </year>
      <volume>
       99
      </volume>
      <fpage>
       632
      </fpage>
      <lpage>
       641
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhvFWmsbs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23357453
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2012.12.044
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lazaraviciute
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Kauser
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Haggarty
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Bhattacharya
        </surname>
        <given-names>
         S
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       840
      </fpage>
      <lpage>
       852
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXkt1ygsbk%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24961233
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmu033
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ducreux
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genome-wide analysis of DNA methylation in buccal cells of children conceived through IVF and ICSI
      </article-title>
      <source>
       Genes
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1912
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XptVKluw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       34946866
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8701402
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/genes12121912
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Koeck
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       At age 9, the methylome of assisted reproductive technology children that underwent embryo culture in different media is not significantly different on a genome-wide scale
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2022
      </year>
      <volume>
       37
      </volume>
      <fpage>
       2709
      </fpage>
      <lpage>
       2721
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXpsF2ltr4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       36206092
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9627755
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deac213
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mulder
        </surname>
        <given-names>
         CL
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Comparison of DNA methylation patterns of parentally imprinted genes in placenta derived from IVF conceptions in two different culture media
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2020
      </year>
      <volume>
       35
      </volume>
      <fpage>
       516
      </fpage>
      <lpage>
       528
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitVKqt7bO
      </pub-id>
      <pub-id pub-id-type="pmid">
       32222762
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7105329
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deaa004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Oliver
        </surname>
        <given-names>
         VF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Defects in imprinting and genome-wide DNA methylation are not common in the in vitro fertilization population
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2012
      </year>
      <volume>
       97
      </volume>
      <fpage>
       147
      </fpage>
      <lpage>
       53.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xht12rtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       22112648
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2011.10.027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Whitelaw
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Epigenetic status in the offspring of spontaneous and assisted conception
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       1452
      </fpage>
      <lpage>
       1458
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhtVaks7nI
      </pub-id>
      <pub-id pub-id-type="pmid">
       24812310
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Esteki
        </surname>
        <given-names>
         MZ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       In vitro fertilization does not increase the incidence of de novo copy number alterations in fetal and placental lineages
      </article-title>
      <source>
       Nat. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1699
      </fpage>
      <lpage>
       1705
      </lpage>
      <pub-id pub-id-type="doi">
       10.1038/s41591-019-0620-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Luiza
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Early Human Development Premature birth, low birth weight, small for gestational age and chronic non-communicable diseases in adult life: a systematic review with meta-analysis
      </article-title>
      <source>
       Early Hum. Dev.
      </source>
      <year>
       2020
      </year>
      <volume>
       149
      </volume>
      <fpage>
       105154
      </fpage>
      <pub-id pub-id-type="doi">
       10.1016/j.earlhumdev.2020.105154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bhatti
        </surname>
        <given-names>
         JS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial dysfunction and oxidative stress in metabolic disorders—a step towards mitochondria based therapeutic strategies
      </article-title>
      <source>
       Biochim. Biophys. Acta Mol. Basis Dis.
      </source>
      <year>
       2018
      </year>
      <volume>
       1863
      </volume>
      <fpage>
       1066
      </fpage>
      <lpage>
       1077
      </lpage>
      <pub-id pub-id-type="doi">
       10.1016/j.bbadis.2016.11.010
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schaefer
        </surname>
        <given-names>
         AM
        </given-names>
       </name>
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Turnbull
        </surname>
        <given-names>
         DM
        </given-names>
       </name>
       <name>
        <surname>
         Taylor
        </surname>
        <given-names>
         RW
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Endocrine disorders in mitochondrial disease
      </article-title>
      <source>
       Mol. Cell. Endocrinol.
      </source>
      <year>
       2013
      </year>
      <volume>
       379
      </volume>
      <fpage>
       2
      </fpage>
      <lpage>
       11
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhtVehsLfE
      </pub-id>
      <pub-id pub-id-type="pmid">
       23769710
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3820028
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.mce.2013.06.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses
      </article-title>
      <source>
       Pediatrics
      </source>
      <year>
       2008
      </year>
      <volume>
       122
      </volume>
      <fpage>
       1003
      </fpage>
      <lpage>
       1008
      </lpage>
      <pub-id pub-id-type="pmid">
       18977979
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1542/peds.2007-3502
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         von Kleist-Retzow
        </surname>
        <given-names>
         J-C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Antenatal manifestations of mitochondrial respiratory chain deficiency
      </article-title>
      <source>
       J. Pediatr.
      </source>
      <year>
       2003
      </year>
      <volume>
       143
      </volume>
      <fpage>
       208
      </fpage>
      <lpage>
       212
      </lpage>
      <pub-id pub-id-type="doi">
       10.1067/S0022-3476(03)00130-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Casteels
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial 16189 variant, thinnnes at birth, and type-2 diabetes
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       1999
      </year>
      <volume>
       353
      </volume>
      <fpage>
       1499
      </fpage>
      <lpage>
       1500
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DyaK1M3kslartQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10232327
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(98)05817-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Casteels
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial 16189 variant, thinness at birth, and type-2 diabetes
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       1999
      </year>
      <volume>
       353
      </volume>
      <fpage>
       1499
      </fpage>
      <lpage>
       1500
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DyaK1M3kslartQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10232327
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(98)05817-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ebner
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial haplogroup T is associated with obesity in Austrian juveniles and adults
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2015
      </year>
      <volume>
       10
      </volume>
      <fpage>
       e0135622
      </fpage>
      <pub-id pub-id-type="pmid">
       26322975
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4556186
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0135622
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Flaquer
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial genetic variants identified to be associated with BMI in adults
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2014
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e105116
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PLoSO...9j5116F
      </pub-id>
      <pub-id pub-id-type="pmid">
       25153900
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4143221
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0105116
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Knoll
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA variants in obesity
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2014
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e94882
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PLoSO...994882K
      </pub-id>
      <pub-id pub-id-type="pmid">
       24788344
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4008486
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0094882
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         TL
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic association study of common mitochondrial variants on body fat mass
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2011
      </year>
      <volume>
       6
      </volume>
      <fpage>
       21595
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2011PLoSO...621595Y
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0021595
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Parker
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Phillips
        </surname>
        <given-names>
         DIW
        </given-names>
       </name>
       <name>
        <surname>
         Cockington
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Cull
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Poulton
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       A common mitchondrial DNA variant is associated with thinness in mothers and their 20-yr-old offspring
      </article-title>
      <source>
       Am. J. Physiol. Endocrinol. Metab.
      </source>
      <year>
       2005
      </year>
      <volume>
       289
      </volume>
      <fpage>
       E1110
      </fpage>
      <lpage>
       E1114
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XlslKqtA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       15998658
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/ajpendo.00600.2004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nardelli
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Haplogroup T is an obesity risk factor: mitochondrial DNA haplotyping in a morbid obese population from Southern Italy
      </article-title>
      <source>
       Biomed. Res. Int.
      </source>
      <year>
       2013
      </year>
      <volume>
       2013
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1155/2013/631082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goisis
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Remes
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Martikainen
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Klemetti
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Myrskylä
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Medically assisted reproduction and birth outcomes: a within-family analysis using Finnish population registers
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2019
      </year>
      <volume>
       393
      </volume>
      <fpage>
       1225
      </fpage>
      <lpage>
       1232
      </lpage>
      <pub-id pub-id-type="pmid">
       30655015
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(18)31863-4
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Amaral
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Lourenço
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Marques
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Ramalho-Santos
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondria functionality and sperm quality
      </article-title>
      <source>
       Reproduction
      </source>
      <year>
       2013
      </year>
      <volume>
       146
      </volume>
      <fpage>
       163
      </fpage>
      <lpage>
       174
      </lpage>
      <pub-id pub-id-type="doi">
       10.1530/REP-13-0178
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ameele
        </surname>
        <given-names>
         JVan
        </given-names>
       </name>
       <name>
        <surname>
         Den
        </surname>
        <given-names>
         Li,AYZ
        </given-names>
       </name>
       <name>
        <surname>
         Ma
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial heteroplasmy beyond the oocyte bottleneck
      </article-title>
      <source>
       Semin. Cell Dev. Biol.
      </source>
      <year>
       2020
      </year>
      <volume>
       97
      </volume>
      <fpage>
       156
      </fpage>
      <lpage>
       166
      </lpage>
      <pub-id pub-id-type="pmid">
       31611080
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.semcdb.2019.10.001
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cecchino
        </surname>
        <given-names>
         GN
        </given-names>
       </name>
       <name>
        <surname>
         D
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Garcia-velasco
        </surname>
        <given-names>
         JA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA copy number as a predictor of embryo viability
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2019
      </year>
      <volume>
       111
      </volume>
      <fpage>
       205
      </fpage>
      <lpage>
       211
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXjtVSisQ%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       30611549
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2018.11.021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Dumollard
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Duchen
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Carroll
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The role of mitochondrial function in the oocyte and embryo
      </article-title>
      <source>
       Curr. Top. Dev. Biol.
      </source>
      <year>
       2007
      </year>
      <volume>
       77
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       49
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2sXmt1Gltb4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       17222699
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0070-2153(06)77002-8
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gu
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes Ling
      </article-title>
      <source>
       Cell Mol. Life Sci.
      </source>
      <year>
       2015
      </year>
      <volume>
       72
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       271
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhs12nt7rN
      </pub-id>
      <pub-id pub-id-type="pmid">
       25280482
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00018-014-1739-4
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="other">
      Otten, A. B. C. &amp; Smeets, H. J. M. Evolutionary defined role of the mitochondrial DNA in fertility, disease and ageing.
      <italic>
       Hum. Reprod. Update
      </italic>
      <bold>
       21
      </bold>
      , 671–689 (2015).
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ramalho-Santos
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial functionality in reproduction: from gonads and gametes to embryos and embryonic stem cells
      </article-title>
      <source>
       Hum. Reprod. Update
      </source>
      <year>
       2009
      </year>
      <volume>
       15
      </volume>
      <fpage>
       553
      </fpage>
      <lpage>
       572
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXhtVals7nI
      </pub-id>
      <pub-id pub-id-type="pmid">
       19414527
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humupd/dmp016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Chao
        </surname>
        <given-names>
         H-T
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Repeated ovarian stimulations induce oxidative damage and mitochondrial DNA mutations in mouse ovaries
      </article-title>
      <source>
       Ann. N. Y. Acad. Sci.
      </source>
      <year>
       2005
      </year>
      <volume>
       1042
      </volume>
      <fpage>
       148
      </fpage>
      <lpage>
       156
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2005NYASA1042..148C
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2MXot1Cqsbs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       15965057
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1196/annals.1338.016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         TC
        </given-names>
       </name>
       <name>
        <surname>
         Kubisch
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
       <name>
        <surname>
         Brenner
        </surname>
        <given-names>
         CA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA deletions in rhesus macaque oocytes and embryos
      </article-title>
      <source>
       Mol. Hum. Reprod.
      </source>
      <year>
       2005
      </year>
      <volume>
       11
      </volume>
      <fpage>
       785
      </fpage>
      <lpage>
       789
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XhtFahtrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       16373367
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molehr/gah227
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ge
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Impaired mitochondrial function in murine oocytes is associated with controlled ovarian hyperstimulation and in vitro maturation
      </article-title>
      <source>
       Reprod. Fertil. Dev.
      </source>
      <year>
       2012
      </year>
      <volume>
       24
      </volume>
      <fpage>
       945
      </fpage>
      <lpage>
       952
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xht1Grs7vK
      </pub-id>
      <pub-id pub-id-type="pmid">
       22935155
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1071/RD11212
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schon
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         DiMauro
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Hirano
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Human mitochondrial DNA: roles of inherited and somatic mutations
      </article-title>
      <source>
       Nat. Rev. Genet.
      </source>
      <year>
       2012
      </year>
      <volume>
       13
      </volume>
      <fpage>
       878
      </fpage>
      <lpage>
       890
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38Xhs1OgsLfO
      </pub-id>
      <pub-id pub-id-type="pmid">
       23154810
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3959762
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrg3275
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kennedy
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
       <name>
        <surname>
         Salk
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Schmitt
        </surname>
        <given-names>
         MW
        </given-names>
       </name>
       <name>
        <surname>
         Loeb
        </surname>
        <given-names>
         LA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Ultra-sensitive sequencing reveals an age-related increase in somatic mitochondrial mutations that are inconsistent with oxidative damage
      </article-title>
      <source>
       PLoS Genet
      </source>
      <year>
       2013
      </year>
      <volume>
       9
      </volume>
      <fpage>
       e1003794
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsFKitb3I
      </pub-id>
      <pub-id pub-id-type="pmid">
       24086148
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3784509
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pgen.1003794
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Naue
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Evidence for frequent and tissue-specific sequence heteroplasmy in human mitochondrial DNA
      </article-title>
      <source>
       Mitochondrion
      </source>
      <year>
       2015
      </year>
      <volume>
       20
      </volume>
      <fpage>
       82
      </fpage>
      <lpage>
       94
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFygsbzM
      </pub-id>
      <pub-id pub-id-type="pmid">
       25526677
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.mito.2014.12.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nekhaeva
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Clonally expanded mtDNA point mutations are abundant in individual cells of human tissues
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2002
      </year>
      <volume>
       99
      </volume>
      <fpage>
       5521
      </fpage>
      <lpage>
       5526
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2002PNAS...99.5521N
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD38XjtFKltrk%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       11943860
      </pub-id>
      <pub-id pub-id-type="pmcid">
       122802
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.072670199
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sanchez-Contreras
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The multi-tissue landscape of somatic mtDNA mutations indicates tissue-specific accumulation and removal in aging
      </article-title>
      <source>
       Elife
      </source>
      <year>
       2023
      </year>
      <volume>
       12
      </volume>
      <fpage>
       e83395
      </fpage>
      <pub-id pub-id-type="pmid">
       36799304
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10072880
      </pub-id>
      <pub-id pub-id-type="doi">
       10.7554/eLife.83395
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Herrero-Martin
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A MELAS/MERRF phenotype associated with the mitochondrial DNA 5521G&gt;A mutation
      </article-title>
      <source>
       J. Neurol. Neurosurg. Psychiatry
      </source>
      <year>
       2010
      </year>
      <volume>
       81
      </volume>
      <fpage>
       471
      </fpage>
      <lpage>
       472
      </lpage>
      <pub-id pub-id-type="pmid">
       20360171
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/jnnp.2009.173831
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Pathogenic mitochondrial DNA 3243A&gt;G mutation: from genetics to phenotype
      </article-title>
      <source>
       Front. Genet.
      </source>
      <year>
       2022
      </year>
      <volume>
       13
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       14
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022FrMat...9....1L
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fu
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Broadening the phenotype of m.5703G&gt;A mutation in mitochondrial tRNAAsn gene from mitochondrial myopathy to myoclonic epilepsy with ragged red fibers syndrome
      </article-title>
      <source>
       Chin. Med. J.
      </source>
      <year>
       2019
      </year>
      <volume>
       132
      </volume>
      <fpage>
       865
      </fpage>
      <lpage>
       867
      </lpage>
      <pub-id pub-id-type="pmid">
       30897601
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6595846
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/CM9.0000000000000151
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kleijkers
        </surname>
        <given-names>
         SHM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       IVF culture medium affects post-natal weight in humans during the first 2 years of life
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2014
      </year>
      <volume>
       29
      </volume>
      <fpage>
       661
      </fpage>
      <lpage>
       669
      </lpage>
      <pub-id pub-id-type="pmid">
       24549211
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/deu025
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Pejaver, V. et al. Inferring the molecular and phenotypic impact of amino acid variants with MutPred2.
      <italic>
       Nat. Commun.
      </italic>
      <bold>
       11
      </bold>
      , 5918 (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lott
        </surname>
        <given-names>
         MT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       mtDNA Variation and Analysis Using Mitomap and Mitomaster
      </article-title>
      <source>
       Curr. Protoc. Bioinforma.
      </source>
      <year>
       2013
      </year>
      <volume>
       44
      </volume>
      <fpage>
       1.23.1
      </fpage>
      <lpage>
       26
      </lpage>
      <pub-id pub-id-type="doi">
       10.1002/0471250953.bi0123s44
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         McCormick
        </surname>
        <given-names>
         EM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation
      </article-title>
      <source>
       Hum. Mutat.
      </source>
      <year>
       2020
      </year>
      <volume>
       41
      </volume>
      <fpage>
       2028
      </fpage>
      <lpage>
       2057
      </lpage>
      <pub-id pub-id-type="pmid">
       32906214
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7717623
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/humu.24107
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gorman
        </surname>
        <given-names>
         GS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial diseases
      </article-title>
      <source>
       Nat. Rev. Dis. Prim.
      </source>
      <year>
       2016
      </year>
      <volume>
       2
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       23
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stewart
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The dynamics of mitochondrial DNA heteroplasmy: implications for human health and disease
      </article-title>
      <source>
       Nat. Rev. Genet.
      </source>
      <year>
       2015
      </year>
      <volume>
       16
      </volume>
      <fpage>
       530
      </fpage>
      <lpage>
       542
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXhtlKnsLnK
      </pub-id>
      <pub-id pub-id-type="pmid">
       26281784
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrg3966
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gómez-Durán
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2010
      </year>
      <volume>
       19
      </volume>
      <fpage>
       3343
      </fpage>
      <lpage>
       3353
      </lpage>
      <pub-id pub-id-type="pmid">
       20566709
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/ddq246
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Montiel-Sosa
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Differences of sperm motility in mitochondrial DNA haplogroup U sublineages
      </article-title>
      <source>
       Gene
      </source>
      <year>
       2006
      </year>
      <volume>
       368
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD28XhslKhs7c%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       16326035
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.gene.2005.09.015
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Payne
        </surname>
        <given-names>
         BaI
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Universal heteroplasmy of human mitochondrial DNA
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2013
      </year>
      <volume>
       22
      </volume>
      <fpage>
       384
      </fpage>
      <lpage>
       390
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhvV2gtr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       23077218
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/dds435
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hahn
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Zuryn
        </surname>
        <given-names>
         S
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The cellular mitochondrial genome landscape in disease
      </article-title>
      <source>
       Trends Cell Biol.
      </source>
      <year>
       2018
      </year>
      <volume>
       xx
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       14
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Keogh
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Chinnery
        </surname>
        <given-names>
         PF
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Hereditary mtDNA heteroplasmy: a baseline for aging?
      </article-title>
      <source>
       Cell Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       18
      </volume>
      <fpage>
       463
      </fpage>
      <lpage>
       464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsFGnsLjP
      </pub-id>
      <pub-id pub-id-type="pmid">
       24093673
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cmet.2013.09.015
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ross
        </surname>
        <given-names>
         JJM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Germline mitochondrial DNA mutations aggravate ageing and can impair brain development
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2013
      </year>
      <volume>
       501
      </volume>
      <fpage>
       412
      </fpage>
      <lpage>
       415
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2013Natur.501..412R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhtlCgtL3L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23965628
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3820420
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nature12474
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ross
        </surname>
        <given-names>
         JM
        </given-names>
       </name>
       <name>
        <surname>
         Coppotelli
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Hoffer
        </surname>
        <given-names>
         BJ
        </given-names>
       </name>
       <name>
        <surname>
         Olson
        </surname>
        <given-names>
         L
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Maternally transmitted mitochondrial DNA mutations can reduce lifespan
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2014
      </year>
      <volume>
       4
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014NatSR...4E6569R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXksVyru78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       25299268
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4190956
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/srep06569
      </pub-id>
      <elocation-id>
       6569
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Picca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration
      </article-title>
      <source>
       Exp. Gerontol.
      </source>
      <year>
       2023
      </year>
      <volume>
       178
      </volume>
      <fpage>
       112203
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXhtVOhsLnE
      </pub-id>
      <pub-id pub-id-type="pmid">
       37172915
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.exger.2023.112203
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kang
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Age-related accumulation of somatic mitochondrial DNA mutations in adult-derived human iPSCs
      </article-title>
      <source>
       Cell Stem Cell
      </source>
      <year>
       2016
      </year>
      <volume>
       18
      </volume>
      <fpage>
       625
      </fpage>
      <lpage>
       636
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XmtFCitL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27151456
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.stem.2016.02.005
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Rebolledo-Jaramillo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maternal age effect and severe germ-line bottleneck in the inheritance of human mitochondrial DNA
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2014
      </year>
      <volume>
       111
      </volume>
      <fpage>
       15474
      </fpage>
      <lpage>
       15479
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2014PNAS..11115474R
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhslKmtbzJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25313049
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4217420
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.1409328111
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zaidi
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Bottleneck and selection in the germline and maternal age influence transmission of mitochondrial DNA in human pedigrees
      </article-title>
      <source>
       Proc. Natl Acad. Sci. USA
      </source>
      <year>
       2019
      </year>
      <volume>
       116
      </volume>
      <fpage>
       25172
      </fpage>
      <lpage>
       25178
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019PNAS..11625172Z
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXitl2hurjJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       31757848
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6911200
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1073/pnas.1906331116
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arbeithuber
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Age-related accumulation of de novo mitochondrial mutations in mammalian oocytes and somatic tissues
      </article-title>
      <source>
       PLoS Biol.
      </source>
      <year>
       2020
      </year>
      <volume>
       18
      </volume>
      <fpage>
       e3000745
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXhsVeqtL3L
      </pub-id>
      <pub-id pub-id-type="pmid">
       32667908
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7363077
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pbio.3000745
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Burgstaller
        </surname>
        <given-names>
         JP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Large-scale genetic analysis reveals mammalian mtDNA heteroplasmy dynamics and variance increase through lifetimes and generations
      </article-title>
      <source>
       Nat. Commun.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       12
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXht1CgurnI
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41467-018-04797-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kiserud
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The World Health Organization fetal growth charts: concept, findings, interpretation, and application
      </article-title>
      <source>
       Am. J. Obstet. Gynecol.
      </source>
      <year>
       2018
      </year>
      <volume>
       218
      </volume>
      <fpage>
       S619
      </fpage>
      <lpage>
       S629
      </lpage>
      <pub-id pub-id-type="pmid">
       29422204
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.ajog.2017.12.010
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Schimmel
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of maternal age and parity on maternal and neonatal outcome
      </article-title>
      <source>
       Arch. Gynecol. Obstet.
      </source>
      <year>
       2015
      </year>
      <volume>
       291
      </volume>
      <fpage>
       793
      </fpage>
      <lpage>
       798
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhsFyit77I
      </pub-id>
      <pub-id pub-id-type="pmid">
       25227657
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00404-014-3469-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wang
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Changing trends of birth weight with maternal age: a cross-sectional study in Xi’an city of Northwestern China
      </article-title>
      <source>
       BMC Pregnancy Childbirth
      </source>
      <year>
       2020
      </year>
      <volume>
       20
      </volume>
      <pub-id pub-id-type="pmid">
       33256654
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7708914
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12884-020-03445-2
      </pub-id>
      <elocation-id>
       744
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR92">
     <label>
      92.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Floros
        </surname>
        <given-names>
         VI
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Segregation of mitochondrial DNA heteroplasmy through a developmental genetic bottleneck in human embryos
      </article-title>
      <source>
       Nat. Cell Biol.
      </source>
      <year>
       2018
      </year>
      <volume>
       20
      </volume>
      <fpage>
       144
      </fpage>
      <lpage>
       151
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXkslGis78%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29335530
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6551220
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41556-017-0017-8
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR93">
     <label>
      93.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wei
        </surname>
        <given-names>
         W
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Germline selection shapes human mitochondrial DNA diversity
      </article-title>
      <source>
       Science
      </source>
      <year>
       2019
      </year>
      <volume>
       364
      </volume>
      <fpage>
       eaau6520
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1MXhtVKgtr7N
      </pub-id>
      <pub-id pub-id-type="pmid">
       31123110
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/science.aau6520
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR94">
     <label>
      94.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mak
        </surname>
        <given-names>
         W
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       794
      </lpage>
      <pub-id pub-id-type="pmid">
       26908846
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4791919
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew024
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR95">
     <label>
      95.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         LaMarca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Polyzos
        </surname>
        <given-names>
         NP
        </given-names>
       </name>
       <name>
        <surname>
         Seed
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         Khalaf
        </surname>
        <given-names>
         Y
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Live birth and perinatal outcomes following stimulated and unstimulated IVF: analysis of over two decades of a nationwide data
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2261
      </fpage>
      <lpage>
       2267
      </lpage>
      <pub-id pub-id-type="pmid">
       27591229
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew184
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR96">
     <label>
      96.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sunkara
        </surname>
        <given-names>
         SK
        </given-names>
       </name>
       <name>
        <surname>
         La Marca
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Seed
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         Khalaf
        </surname>
        <given-names>
         Y
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2015
      </year>
      <volume>
       30
      </volume>
      <fpage>
       1473
      </fpage>
      <lpage>
       1480
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhsF2nt77N
      </pub-id>
      <pub-id pub-id-type="pmid">
       25883033
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dev076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR97">
     <label>
      97.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Magnusson
        </surname>
        <given-names>
         Å
        </given-names>
       </name>
       <name>
        <surname>
         Källen
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Thurin-Kjellberg
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Bergh
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The number of oocytes retrieved during IVF: a balance between efficacy and safety
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       58
      </fpage>
      <lpage>
       64
      </lpage>
      <pub-id pub-id-type="pmid">
       29136154
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dex334
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR98">
     <label>
      98.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Nelissen
        </surname>
        <given-names>
         EC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Further evidence that culture media affect perinatal outcome: findings after transfer of fresh and cryopreserved embryos
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2012
      </year>
      <volume>
       27
      </volume>
      <fpage>
       1966
      </fpage>
      <lpage>
       1976
      </lpage>
      <pub-id pub-id-type="pmid">
       22552689
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/des145
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR99">
     <label>
      99.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis
      </article-title>
      <source>
       Fertil. Steril.
      </source>
      <year>
       2012
      </year>
      <volume>
       97
      </volume>
      <fpage>
       1331
      </fpage>
      <lpage>
       1337.e4
      </lpage>
      <pub-id pub-id-type="pmid">
       22480819
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.fertnstert.2012.02.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR100">
     <label>
      100.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Danan
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection
      </article-title>
      <source>
       Am. J. Hum. Genet.
      </source>
      <year>
       1999
      </year>
      <volume>
       65
      </volume>
      <fpage>
       463
      </fpage>
      <lpage>
       473
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaK1MXlsFSgsrY%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10417289
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1377945
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1086/302484
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR101">
     <label>
      101.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Semen quality of young adult ICSI offspring: the first results
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2016
      </year>
      <volume>
       31
      </volume>
      <fpage>
       2811
      </fpage>
      <lpage>
       2820
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BC2svmvVyltA%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27707840
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew245
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR102">
     <label>
      102.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Belva
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Reproductive hormones of ICSI-conceived young adult men: the first results
      </article-title>
      <source>
       Hum. Reprod.
      </source>
      <year>
       2017
      </year>
      <volume>
       32
      </volume>
      <fpage>
       439
      </fpage>
      <lpage>
       446
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXitFCku77J
      </pub-id>
      <pub-id pub-id-type="pmid">
       28007789
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/humrep/dew324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR103">
     <label>
      103.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Spits
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Whole-genome multiple displacement amplification from single cells
      </article-title>
      <source>
       Nat. Protoc.
      </source>
      <year>
       2006
      </year>
      <volume>
       1
      </volume>
      <fpage>
       1965
      </fpage>
      <lpage>
       1970
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD2sXhtFagtrvM
      </pub-id>
      <pub-id pub-id-type="pmid">
       17487184
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nprot.2006.326
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR104">
     <label>
      104.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mertens
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Detection of heteroplasmic variants in the mitochondrial genome through massive parallel sequencing
      </article-title>
      <source>
       Bio-Protoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       19
      </lpage>
      <pub-id pub-id-type="doi">
       10.21769/BioProtoc.3283
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR105">
     <label>
      105.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zambelli
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Accurate and comprehensive analysis of single nucleotide variants and large deletions of the human mitochondrial genome in DNA and single cells
      </article-title>
      <source>
       Eur. J. Hum. Genet.
      </source>
      <year>
       2017
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1229
      </fpage>
      <lpage>
       1236
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtlyjtb%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       28832570
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5643964
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/ejhg.2017.129
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR106">
     <label>
      106.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Weissensteiner
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       mtDNA-Server: next-generation sequencing data analysis of human mitochondrial DNA in the cloud
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2016
      </year>
      <volume>
       44
      </volume>
      <fpage>
       gkw247
      </fpage>
      <pub-id pub-id-type="doi">
       10.1093/nar/gkw247
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR107">
     <label>
      107.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cibulskis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
      </article-title>
      <source>
       Nat. Biotechnol.
      </source>
      <year>
       2013
      </year>
      <volume>
       31
      </volume>
      <fpage>
       213
      </fpage>
      <lpage>
       219
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXjsFCntbc%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23396013
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3833702
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nbt.2514
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR108">
     <label>
      108.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Castellana
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Rónai
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Mazza
        </surname>
        <given-names>
         T
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       MitImpact: an exhaustive collection of pre-computed pathogenicity predictions of human mitochondrial non-synonymous variants
      </article-title>
      <source>
       Hum. Mutat.
      </source>
      <year>
       2015
      </year>
      <volume>
       36
      </volume>
      <fpage>
       E2413
      </fpage>
      <lpage>
       E2422
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2MXit12lt7g%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       25516408
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/humu.22720
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR109">
     <label>
      109.
     </label>
     <mixed-citation publication-type="other">
      Sonney, S. et al. Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP.
      <italic>
       PLoS Comput. Biol.
      </italic>
      <bold>
       13
      </bold>
      , e1005867 (2017).
     </mixed-citation>
    </ref>
    <ref id="CR110">
     <label>
      110.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mertens
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Mitochondrial DNA variants segregate during human preimplantation development into genetically different cell lineages that are maintained postnatally
      </article-title>
      <source>
       Hum. Mol. Genet.
      </source>
      <year>
       2022
      </year>
      <volume>
       31
      </volume>
      <fpage>
       3629
      </fpage>
      <lpage>
       3642
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3sXptFaksLY%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35285472
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9616571
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/hmg/ddac059
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR111">
     <label>
      111.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zambelli
        </surname>
        <given-names>
         F
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Random mutagenesis, clonal events and embryonic or somatic origin determine the mitochondrial DNA variant type and load in human pluripotent stem cells
      </article-title>
      <source>
       Stem Cell Rep.
      </source>
      <year>
       2018
      </year>
      <volume>
       11
      </volume>
      <fpage>
       102
      </fpage>
      <lpage>
       114
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhtF2mu7rE
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.stemcr.2018.05.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR112">
     <label>
      112.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Spelbrink
        </surname>
        <given-names>
         JN
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges
      </article-title>
      <source>
       IUBMB Life
      </source>
      <year>
       2010
      </year>
      <volume>
       62
      </volume>
      <fpage>
       19
      </fpage>
      <lpage>
       32
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3cXktlemtw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       20014006
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/iub.282
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec14">
     <title>
      Taarifa za ziada
     </title>
     <p id="Par36">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Description of Additional Supplementary Files
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM4" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM4_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 1
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM5" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM5_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 2
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM6" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM6_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 3
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM7" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM7_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 4
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM8" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM8_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 5
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM9" xlink:title="Supplementary information">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM9_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Supplementary Data 6
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM10" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM10_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
    <sec id="Sec15">
     <title>
      Data ya chanzo
     </title>
     <p id="Par37">
      <supplementary-material content-type="local-data" id="MOESM11" xlink:title="Source data">
       <media mime-subtype="vnd.ms-excel" mimetype="application" xlink:href="MediaObjects/41467_2024_45446_MOESM11_ESM.xlsx">
        <caption xml:lang="en">
         <p>
          Source Data
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title>
    Taarifa za ziada
   </title>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-45446-1">
     https://doi.org/10.1038/s41467-024-45446-1
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
